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 EXECUTIVE SUMMARY 
Despite tremendous and ongoing advances in treatment, HIV remains a global health problem. Alt-
hough for some regions, in which Anti Retroviral Therapy (ART) coverage is low, access to ART for all 
in need is focused 
1
, problems in countries that have ART coverage of nearly 100% and sustained low 
morbidity and mortality due to HIV/AIDS 
2,3
 pertain largely to the consequences of lifelong treatment, 
adherence, and maintaining quality of life. Persons living with HIV (PLWH) on ART, despite continually 
improving treatment options with a relatively low side effects profile, are challenged with numerous and 
often fluctuating and debilitating symptoms due to the illness itself, comorbidities and medication side 
effects 
4
.   Health-care providers are important collaborators in facilitating effective symptom manage-
ment support to keep limitations on productivity, social engagement, and well-being 
5,6
 as low as possible 
7,8
. Moreover, since an ongoing rigorously designed intervention trial substantiates evidence that ART can 
prevent the sexual transmission of HIV 
9
, health care providers are more than ever asked to support pa-
tients’ efforts to achieve and maintain adherence in order to ensure ART effectiveness and viral suppres-
sion. Caring for PLWH, therefore, involves assisting patients in adhering to their medication regimen 
despite intrusive and non-treatable side effects. Engaging in quality of life issues comes to the fore. Due 
to the individual interpretation and perception of symptoms 
10
 and their link to the efforts patients living 
with a chronic illness must make on an everyday basis in order to live as normal a life as possible 
11,12
, 
identifying symptoms that need management, however, is challenging. Comparing traditionally used “ob-
jective” measures, i.e. symptom severity or frequency, with concerns of patients in terms of self-
management in daily life 
13
, makes clear that traditionally employed parameters may not be those of most 
concern to patients and that the patients’ perspective on consequences of a symptom for daily life may be 
neglected. As in clinical encounters, patients often describe their life with symptoms using sentences like 
“I can’t manage symptom x or y anymore,” or “well, yes, symptoms are well manageable,” thus directly 
referring to their ability to influence the impact of the symptoms on their life, we suggest “perceived 
symptom manageability” as an apt concept for describing PLWHs’ lived experience with symptoms and 
also as a potential means of identifying symptoms that need attention. Our assumptions require verifica-
 tion, however, before the concept can be recommended for use in clinical practice. The aim of this PhD 
project was thus to explore the concept and its potential for identifying symptoms that need management. 
As the concept (manageability) is well-known, but has not yet been used in relation to symptoms, 
the procedural steps of concept synthesis 
14
 were used to transfer the concept from its current use (“man-
ageability”) to a use with symptoms (“perceived symptom manageability”) and to define attributes of the 
concept. To follow the steps of concept synthesis, a mixed method triangulation design 
15
 seemed appro-
priate. Qualitative and quantitative analyses were conducted independently and systematically combined 
at the interpretation phases of the concept synthesis. Conclusions as to the concept’s constituents and its 
usefulness in identifying symptoms that need management were then drawn (see diagram next page) 
based on these results. 
The PhD project was conducted within the scope of a larger, multi-center mixed methods study ex-
ploring symptom experience of PLWH, The Symptoms and other Life Experiences and Adherence (SO-
LEXA) study, which was conducted by our team from 2003 to 2006. For the PhD project, we thus partly 
drew on existing data taken from the overarching study. The patients we recruited for the studies were all 
undergoing treatment at one of the four centers of the Swiss HIV Cohort Study (SHCS) (Basel, Bern, 
Zürich, and St. Gallen).  
 Diagram 1. The combined integration and research process 
 
Concept synthesis is deemed especially useful in the case of concepts that have already been used, 
but have not yet been described in a specific area or context 
14
. By broadly exploring as many current uses 
of the concept as possible, summarizing core aspects of the concept, and applying it to perceived symp-
toms, a new area of use was added and a new perspective was explored 
16
. Study 1 comprises these first 
steps of the concept synthesis process 
14
 and reports the transfer of “manageability” to “perceived symp-
tom manageability” on the basis of data drawn in January 2012 from online databases, thesauruses, and 
dictionaries. We found that “manageability” referred to managing a difficult situation and that social re-
sources as well as individual interpretation were relevant in this regard, thus positioning “manageability” 
in a social and interpretational context that exceeded objective control. We thus preliminarily defined 
“perceived symptom manageability” as “the extent of the perceived ability to bring social and personal 
resources into play to successfully deal with or control symptoms, despite difficulties.” By transferring the 
concept to symptoms, we believe that our working definition represents a promising start to understand 
and address the manageability problems that individual patients face regarding particular symptoms and 
may serve as a basis to identify not only symptoms but also areas of intervention that are of most con-
cern to individual patients. 
In the second study, we further followed the concept synthesis procedure aiming at the empirical 
verification of the formerly developed working definition of “perceived symptom manageability.” 
Drawing from existing SOLEXA data, we conducted a secondary analysis of interviews with 13 HIV 
long-term survivors using conventional content analysis 
17
. This step enabled us to modify and refine the 
definition by integrating key components of the concept according to the lived experience of people 
with HIV, which we were able to capture employing a qualitative approach. More specifically, we found 
that a symptom was perceived as manageable if it was reconcilable with professional, social, and per-
sonal activities. Contributory factors were keeping interference endurable, being embedded in an acces-
sible supportive network of professionals and laypersons, and being placid in the view of HIV.  
We integrated these findings into the theoretical working definition of perceived symptom man-
ageability for long-term HIV survivors, and, thus, transferred the concept’s use from generic to specific: 
“Perceived symptom manageability relates to the extent of the perceived ability to secure information, 
  
and emotional and instrumental support as well as to apply tailored symptom management strategies to 
keep a symptom’s interference with the social, professional, and personal realms at an acceptable level.” 
Study 3 encompasses the quantitative exploration of the perceived manageability of 61 symptoms 
in a sample of 268 persons living with HIV and the further verification of the concept by positioning it 
within the conceptual framework of symptom management in persons living with HIV as suggested by 
Spirig et al. 
10
. In this secondary data analysis employing data collected for the cross-sectional mixed-
method SOLEXA project, perceived manageability of symptoms was identified. Social support, gender, 
age, depressive and anxiety symptoms, traditional symptom experience parameters, and symptom man-
ageability as measured by the HIV Symptom assessment scale and the HIV Symptom manageability 
scale were explored bivariately and multivariately. 
The least manageable symptoms were hair loss, vomiting, insomnia, weight gain in the stomach 
area, decreased ability to withstand psychological strain, anxiousness, skinny arms and legs, depressed 
mood, and fatigue. Multivariately, age (Beta=-0.11; p=.024), symptom distress (Beta=-.62; P<.001) and 
total anxiety and depressive symptoms (Beta=-.18; p=.003) were statistically significant correlates of 
perceived symptom manageability.  
Integration of findings from studies 1-3 
If using a triangulation design, i.e., conducting quantitative and qualitative analytical steps inde-
pendently, the combination of findings is recommended to take place at the interpretation phase of the 
study 
15
. The integration findings from studies 1-3, we employed the systematic steps recommended by 
Farmer et al. 
18, who suggest, first, to develop a “triangulation protocol” in which the distinct steps of 
integration are described 
18,19
. Coding, sorting, and listing findings on one page in order to enable a 
comprehensive assessment of divergence, concordance, or silence between themes from different meth-
ods and studies are the recommended steps. To list uses from our studies, we used convergence coding 
matrices 
19, which enabled the global assessment of concept constituents and of patients’ appraisal of 
symptom manageability in terms of symptoms mentioned in qualitative interviews. From this step, our 
key findings emerged.  
 Key findings  
Key Finding 1 refers to the global assessment of antecedents, attributes, and consequences of per-
ceived symptom manageability, which revealed that the concept’s constituents mainly refer to normali-
zation, i.e. a person’s efforts to live as normally as possible despite the chronic illness 11. Normalizing is 
especially difficult if symptoms are fluctuating, regimens are changing; social interactions and roles 
endangered, or the trajectory of the illness is perceived as fatal 
11
. For PLWH, who must live with many 
untreatable and potentially intrusive symptoms the success of normalization efforts can, therefore, not 
only depend on medical symptom control but also on the extent of how successful they are to keep the 
intrusiveness by the illness and symptoms tolerable. Perceived symptom manageability, thus, refers to 
the perceived ability to lead a normal life despite potentially intrusive symptoms.  
Key Finding 2 relates to the symptoms mentioned in qualitative interviews and the concordance 
assessment of symptom appraisals in qualitative interviews and quantitative survey data. Poorly 
manageable symptoms mainly belong to three clusters of symptoms, namely mood and mind-related 
symptoms, symptoms related to energy and recreation, and physical changes. These symptoms were 
identified concordantly among the least manageable symptoms by the two approaches. Although 
associated with negative health outcomes, many of these symptoms are under-recognized and under-
treated 
20,21
. Overall, we conclude that the concept can be used to recognize symptoms that impede 
normalization, and that symptoms relating to mood and mind, energy and recreation, and physical 
changes need attention due to their potential to negatively impact daily life and consequently adherence 
and quality of life. 
Final reflection: Limitations and recommendations  
While there are indications that “perceived symptom manageability” may be a promising concept 
for identifying symptoms that need management by identifying the patients’ perspective on a life with 
symptoms in a chronic phase of HIV, evidence is far from conclusive. Based mainly on secondary data 
use, further testing the concept using primary data is recommended. 
  
  
Emerging evidence that addressing the emotional situation of patients not only increases 
satisfaction with the health care experience, but may also facilitates adherence 
22
 and reduces perceived 
symptom burden 
23,24
, however, advocates the use of the concept in clinical encounters. Self-
management support must integrate the various ways in which persons with chronic illnesses manage 
their own bodies, experiences, and health choices 
25
; addressing the tensions related to sustaining a 
coherent identity, having valued social roles, and leading a normal life may create context-specific 
opportunities to support patients and facilitate self-management 
26
.  
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Abbreviation  
HIV Human Immunodeficiency Virus 
cART combined Anti Retroviral Therapy 
PLWH Persons Living With HIV 
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 INTRODUCTION 
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BACKGROUND 
Despite tremendous and ongoing advances in treatment, HIV remains a global health problem. Alt-
hough the number of new infections decreased from 3.1 million (Confidence Interval (CI): 2.9 million–3.4 
million) in 1999 to 2.6 million (CI: 2.3–2.8 million) in 2009 and AIDS-related deaths decreased from 2.1 
million CI: 1.9–2.3 million) in 2004 to 1.8 million (CI: 1.6–2.1 million) in 2009, the total number of people 
living with HIV rose from approximately 26.2 million (CI: 24.6–27.8 million) in 1999 to 33.3 million (CI: 
31.4–35.3 million) in 2009 1. There was great improvement with regard to ART coverage and accessibility 
throughout low-income and middle-income countries, as, for instance, 5,254,000 people were receiving 
antiretroviral therapy at the end of 2009, which corresponds to an increase of over 1.2 million people from 
December 2008; representing a 30% rise from a year earlier and a thirteenfold increase over six years., 
There are still differences between resource-limited and resource–affluent settings in view of accessibility 
to ART, however; in North Africa and the Middle East, for example, only 11% of persons in need of ART 
in 2009 were able to access these medications 
2
.  
Whereas the global aim to “achieve universal access to HIV prevention, diagnosis, treatment, care 
and support” 3 (p 3) guides interventions in all areas as a response to HIV and AIDS, depending on a set-
ting's needs and available resources, health care priorities are different 
4
. In high-income countries, indi-
vidualized and highly targeted interventions delivered in specialized settings prevail, whereas in resource-
limited settings, a programmatic public health approach is widely employed that provides standardized 
monitoring and a limited number of regimens to as many people as possible in order to ensure universal 
access to treatment. While for those having access, virological outcomes seem to be similar for both ap-
proaches 
5
, ART coverage is still low in resource-limited areas, and the primary effort goes toward in-
creasing the accessibility and availability of ART. In the western and central parts of Europe, ART cover-
age lies between 90-100% 
6
. As a result, morbidity and mortality due to HIV/AIDS have decreased dra-
matically over the last decades 
7
 and the initial drop in these parameters since the introduction of ART has 
been sustained 
6
.  
These achievements, however, come at a cost: PLWH on ART, despite continually improving 
treatment options with a relatively low side effects profile, are challenged with numerous and often fluc-
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tuating and debilitating symptoms due to the illness itself, comorbidities, and medication side effects. 
Health-care providers play a key role in facilitating effective symptom management to minimize negative 
effects on productivity, social engagement, and wellbeing 
8
 
9
 as low as possible 
10,11
. Moreover, since an 
ongoing rigorous intervention trial substantiates evidence that ART can prevent the sexual transmission of 
HIV 
12
, health care providers are more than ever asked to support patients' efforts to achieve and maintain 
adherence in order to ensure ART effectiveness and viral suppression. Caring for PLWH, therefore, in-
volves assisting patients in adhering to their medication regimen despite intrusive and non-treatable side 
effects, and providing symptom management support for these symptoms comes to the fore. Identifying 
symptoms that need management, however, is challenging, and due to the individual interpretation and 
perception of symptoms 
13
 and their link to the efforts patients living with a chronic illness must make on 
an everyday basis in order to live as normal a life as possible 
14,15
. Although traditional "objective" 
measures to identify symptoms that need management i.e., symptom severity or frequency, are important 
parameters, they are not necessarily of primary concern to PLWHs when it comes to successfully manag-
ing everyday life despite having less treatable symptoms. Effective symptom management support, there-
fore, ideally starts with the identification of symptoms that need management from the patient's view, 
thereby integrating the patient's concerns. 
In the paragraphs that follow, we discuss the situation of PLWH living in Switzerland and the ra-
tionale behind taking a broader perspective than traditional symptom experience dimensions when striving 
to identify symptoms that need management. We also propose a new approach to this challenge. 
Patients living with HIV in Switzerland 
In Switzerland, according to a 2011 estimation issued by the Federal Office of Public Health (FOPH) 
16
 between 19,000 and 26,000 persons are currently living with HIV, and AIDS accounted for less than 100 
deaths in 2009, as opposed to more than 600 in 1995 
17
. In fact, due to nearly area-wide coverage, the life 
expectancy of persons living with HIV (PLWH) on cART rose from 36.1 to 49.4 years 
18
 and as such ap-
proaches normalcy. Consequently, PLWH must nowadays cope with issues related to living with a chronic 
illness 
14
(pp. 10). PLWH have the option to receive state-of-the-art care and treatment either at one of the 
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seven centers enrolled in the Swiss HIV Cohort Study (SHCS), an ongoing multi-center cohort study project 
that was established in 1988 and is focused on patient oriented HIV research, or through a private care pro-
vider. Health care and treatment costs are reimbursed by health insurances independent from the provider. 
Highly tailored symptom management and chronic illness care interventions are available in many of these 
settings. 
CHRONIC CARE MANAGEMENT 
A fundamental change has occurred with regard to health care needs and the delivery system over 
the last 20 years. As a result of the demographic and lifestyle changes as well as medical improvements, 
health care systems are challenged by an increasing number of patients of older age and patients with 
chronic conditions 
19
. The publications "Innovative Care for Chronic Conditions (ICCC) – building 
blocks for action" by the WHO 
19
 and the "Chronic Care Model (CCM)" by Wagner et al (2001) both 
propose a restructuring of the health care environment in response to the increasing number of patients 
suffering from chronic conditions 
20-22
. In the WHO publication, the authors point out that improved, 
comprehensive, and sustainable care for the chronically ill relies on an orchestrated interplay of political 
leaders and policy makers, health care organizations and the community systems, and the people involved 
in managing the chronic condition and the interaction between them. Prepared, informed, and motivated 
health care teams, patients and families, and community supporters interact in a productive and targeted 
manner in order to systematically cover important health care elements, such as managing medication and 
symptoms. The continuity and reliability of relationships and the taking into account of the patients' val-
ues and needs are particularly important components of productive interaction 
22
.  
In many settings, consequently, the perspective of care changed from a provider-focused to a pa-
tient-focused care paradigm. This perspective reinforces collaboration and mutual understanding, which 
seeks to integrate the patient's perspective when tailoring interventions for chronic illness management 
20,23,24
. The chronic illness management approach has become a core element in providing supportive care 
to people living with HIV (PLWH), who, due to highly developed medical therapeutic possibilities, are 
rather living with a chronic condition than an acute illness. 
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As a consequence of this change, symptom management actions have changed from those focus-
ing palliation and symptom alleviation to actions relating to living with a chronic condition. The princi-
pality over care-giving shifted from the health care provider to the patient 
25
; correspondingly, the role of 
the health care providers changed from one who knows and directs to facilitator and skilled companion 
supporting a PLWH who lives independently, and health care providers may invent, adjust or negotiate 
symptom management strategies used by PLWH in order to improve quality of life and health outcomes 
26
. Despite the potential to reduce mortality and morbidity and thus increase the quality of life, many 
patients receiving ART are challenged by symptoms due to medication side effects, comorbidities, and 
the illness itself, and the identification of symptoms that need management is an important topic in 
health care encounters. The first step towards providing tailored and patient-focused symptom manage-
ment support, and not merely "applying" management strategies for a provider-defined symptom to the 
patient 
27
 is the identification of symptoms that potentially need management from the patient's perspec-
tive. The following paragraph highlights the living context of PLWH, and the approaches employed to 
integrate the patient's perspective to identify symptoms that need management. 
Symptom self-management in HIV  
Symptom management is an individual and dynamic task, and due to the symptoms' influence on and 
interference with everyday routines, symptom management is often difficult for PLWHs, their families, and 
health care providers. Living with HIV demands the watchful observation of fairly unpredictable variables 
and the integration of changes into daily living in order to maintain physical and mental well-being 
28,29
. 
Depending on the predictability and expression of symptoms due to medication side effects, the condition 
itself, and comorbidities 
9,30
, maintaining quality of life or working capacity may require day-to-day deci-
sions 
31
 in view of symptom management choices. Being confronted with managing their illness while con-
tinuing with their lives demands specific skills and tasks from PLWH and their families, enabling the skillful 
handling of every-day challenges in various domains 
32
.  
Self-management is widely understood as the day-to-day actions that patients living with a chronic 
condition must take in order minimize the negative consequences of their condition. Self-management 
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actions generally aim at increasing overall well-being, maintaining a given level of health, or slowing 
down decline 
33,34
. Corbin and Strauss 
35
 identified three basic areas of self-management, namely medical 
management, role management and emotional management, in which patients are challenged across a 
range of chronic conditions 
33
. Emotional management, for instance, included coping with unpleasant 
emotions commonly associated with suffering from a chronic illness trajectory, such as fear, anger, or 
frustration. Medication and role management included, for example, adhering to a specifically defined 
diet or medication regimen, and adapting or altering old life roles and creating new ones according to the 
condition's requirements. Nicca, in her dissertation study 
32
 further refined and expanded these areas to 
eight areas specific for PLWH, who, due to the transmission pathway, treatment side effects and stigmati-
zation of HIV, face the additional challenge of managing transmission, disclosure, substance abuse, life-
style, and perhaps most importantly, medication 
32
. From a medical perspective, medication and symptom 
control have first priority; for a patient, however, other self-management areas may temporarily be more 
important. Moreover, despite their distinct nature, areas of self-management are mutually influential. 
Management of a perceived symptom may thus be temporarily intertwined with disclosure or uncertainty 
in view of HIV and progression. Ideally, supporting patients in managing their own symptoms thus in-
volves assessing all self-management areas. 
Health care needs of PLWH are increasingly recognized as those of other populations with chronic 
conditions, and self-management dimensions seem to be similar across different chronic conditions. In a 
recent review, Swendeman, Ingram & Rotheram-Borus identified three broad categories for self-
management that are common across chronic diseases, highlighting elements within these categories that 
are specific to living with HIV/AIDS 
36
. Identified shared categories were physical health, psychological 
functioning, and social relationship, in accordance with the three management areas identified by Lorig & 
Holman (2003) mentioned above: namely, medical management (relating to physical health), emotional 
management (relating to psychological functioning), and role management (corresponding to social rela-
tionship). Categories of symptom management that are specific to living with HIV were, among others, 
maintaining and strengthening the immune system and focusing on activities that reduce stress. In the 
domain of psychological functioning, the authors emphasize what a challenge it is for the PLWH to build 
up self-efficacy and a sense of control regarding the uncertainty inherent to the HIV trajectory, which 
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seems to be an ongoing concern despite good medical control of the virus 
34,37
. Managing transmission 
and disclosure represent further HIV-specific areas for self-management 
38,39
. 
Interventions targeting better symptom management in populations living with HIV have been in-
vestigated in relation to symptom control/alleviation, those investigating adherence, and those related to a 
life with symptoms and the illness. In studies targeting single symptoms, symptom management interven-
tions were successfully employed to decrease symptoms of depression 
40
 or diarrhea 
41
. The use of a 
symptom management manual including self-care strategies for 21 common symptoms, for instance, re-
sulted in a successful reduction of symptom frequency and intensity in the intervention group as com-
pared to the control group (t=2.36, P=0.018) 
42
. The use of a symptom management intervention program 
comprising group teaching followed by telephone counseling was related to increased adherence and im-
proved quality of life 
43,44
, as well as increased self-care abilities in view of managing symptoms. In a 
randomized clinical trial by Webel et al. 
45
, although a peer-based self-care intervention using a HIV self-
care manual was not successful in view of adherence or intensity of perceived symptoms, the intervention 
seemed to have a positive effect on "HIV Mastery" (chi(2)=25.08; p<0.005) and "Disclosure Worries" 
(chi(2)=24.67; p<0.005). In a pilot intervention promoting self-management skills targeting the transition 
to work and work-life balance 
46
, participants' perceived ability to work and balance health, work and 
daily life increased immediately after the intervention; there was a sustained negative impact of perceived 
symptoms on work performance at follow-up, however. A population-specific and culturally sensitive 
intervention targeting emotional distress of African American mothers 
47
 was successfully tested and 
women in the intervention group reported feeling less stigmatized and improved physical function after 
six home visits by nurses. In addition to provider-offered strategies, it seems that to successfully master 
their life with symptoms, patients employ a variety of self-management strategies originating from di-
verse sources 
48
. The use of conventional and complementary treatments, self-comforting, or spiritual care 
was common, and strategies were self-invented or learned from people in the social network. Self-
management strategies used by patients are often symptom-specific 
49-51
. For instance, for peripheral neu-
ropathy, patients employed strategies involving their social network or used complementary medicine or 
consumed substances such as nicotine, alcohol, or street drugs. For depressive symptoms, which are fre-
quently under-identified and under-treated, six self-care categories were discovered in a study of 1217 
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PLWH from Colombia (44%), Norway (66%), Puerto Rico (57%), Taiwan (35%), and the USA (56%): 
"complementary therapies, talking to others, distraction techniques, physical activity, medications, and 
denial/avoidant coping," where the most commonly employed strategies varied by country 
49
. For another 
group of symptoms that seems to be under-recognized 
52
 and difficult to control conventionally, namely, 
cognitive symptoms, PLWH also employ unconventional strategies to keep symptoms tolerable. Patients 
frequently reported using methamphetamine and diverse substances 
53,54
 to alleviate depressive symp-
toms, fatigue and neuropathic symptoms, as well as using marijuana, illicit drugs, and/or heavy alcohol 
intake and smoking to control fatigue and/or confusion/distress 
55
.  These findings indicate the importance 
of increasing recognition of these symptoms in order to arrive at other solutions for self-management.  
Recent publications add to the evidence that bring into play the patients' perception of symptoms 
as the basis for communication between health care providers and patients, which contributes to mutual 
understanding and productive interactions. Nader et al. 
56
 tested the use of a new decision support tool 
to improve the recognition of symptoms that need management and reduce the patients' burden in view 
of symptom assessment. Patients were asked to indicate the most bothersome symptoms within a list of 
20 symptoms validated by PLWH and found that mutual understanding and satisfaction of providers 
and PLWH increased by using this tablet-PC based symptom list. In another publication, a question-
naire integrating aspects important for the management of HIV and related symptoms was adminis-
tered, i.e., health-related quality of life, satisfaction, tolerability, and adherence were assessed and re-
sults show that such a tool may be a novel approach to therapeutic management of PLWH 
57
.  
As above findings suggest, assessments solely focusing symptom expression seem to miss the aspect 
of symptom self-management in daily life, especially of emotional symptoms and those difficult to control 
with medications. Employing, first, an idiom incorporating an individual's lived experience, and, second, a 
patient-defined list of symptoms would additionally integrate the individual perspective of the person con-
cerned 
58,59
. 
In summary, symptom self-management enhancing programs for PLWH provide a fragmented view 
on the life with the illness and associated symptoms. Although there is increasing evidence that symptom 
self-management and interventions focusing self-management support can not only be seen as a summary 
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for strategies aiming at symptom alleviation or total symptom control, but rather as a broad view on symp-
toms encompassing the various aspects of the work required in view of living with a chronic condition, there 
is no concept capturing patients' perspective on how they self-manage symptoms and master their daily 
routine with symptoms.  
The Self-regulatory HIV/AIDS Symptom Management Model (SSMM-HIV) 
13
 
Subjective illness theories such as the Common sense Theory by Leventhal et al.
60
 are useful 
frameworks for understanding the elements contributing to the patients' interpretation of symptoms and 
the importance of the individual perception in relation to subsequent behavior.  
In an attempt to advance the conceptual foundation of care for people living with HIV, Spirig et al. 
applied in 2005 Leventhal et al.'s theory to symptom management in the context of HIV and developed on 
the basis of a critical literature review the Self-regulatory HIV/AIDS Symptom Management Model 
(SSMM-HIV). This model links symptom experience, social support, adherence, and symptom management 
to clinical and individual outcomes, and, as such, accounts for the specific conditions of living with HIV 
61
. 
In the above framework, symptoms are defined as the "patient's responses to the changes in their biopsycho-
social functioning and cognition" (Spirig et al, p.337). In order to understand the individual reactions to 
symptoms and mechanisms for symptom management choices, diverse internal and external factors need to 
be considered (see model below). Above all, a symptom is always perceived and evaluated individually. 
Based on an individual's illness representation, the intrapersonal basis on which symptoms are perceived, an 
individual ascribes identity, cause, timeline, control, consequences and cure probability to a symptom. Ex-
ternal factors, i.e., social support and the wholeness of a person's context, may also shape symptom percep-
tion. Once a symptom is noticed, symptom experience may be described as a function of symptom severi-
ty/intensity, symptom frequency, and associated distress. After having evaluated the symptom, strategies to 
face it are assessed. The term "symptom management" refers to how a patient makes decisions relating to 
symptom management actions, e.g., adherence decisions or seeking information. Outcomes may be meas-
ured as individually perceived quality of life, or assessed in terms of clinical indicators. Illness representa-
tion, influencing factors, social support, symptom experience, symptom management (representing the actu-
al strategies used), and adherence are all contributing to outcomes. It is important to note that Sprig's model 
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is recursive and the elements mutually influential, which means that the linearity suggested in our above 
description is to be seen as an auxiliary construction to better understand the complexity of the entire symp-
tom management task.  
Diagram 1. Self-regulatory HIV/AIDS Symptom Management Model (SSMM-HIV) by Spirig et al. (2005);  
used with permission: Wolters Kluwer Health. 
 
 
 
 
 
 
 
In summary, in the symptom management model described above, a patient's symptom perception 
precedes symptom experience, which constitutes the foundation on which uptake and choice of symptom 
management strategies is based. A patient's individual symptom perception and interpretation, thus, de-
termines the symptoms that need management; it also illustrates that symptom management activities 
taken up by a person are driven by the individual and context. The model also illustrates that symptom 
experience – defined as symptom severity, frequency, and associated distress – only represents one spe-
cific aspect contributing to symptom management in the daily life of PLWH.  
CONCEPTS EMPLOYED TO IDENTIFY SYMPTOMS THAT  
 NEED MANAGEMENT    
In order to identify symptoms that need management, a measure accounting for the change of HIV 
from an acute to a chronic illness is key. Such a measure should, ideally, not only assess symptom ex-
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pression but also dimensions of daily living with symptoms from the patient's perspective. Traditionally, 
symptoms that need management are identified by asking patients about their symptom experience. Alt-
hough a patient's symptom experience is an individually shaped concept and embraces cognitive and 
emotional dimensions, however, it does not account for the daily challenges encountered when living 
with HIV 
32
. When confronted with a symptom, PLWH are concerned about controlling medical parame-
ters and symptom expression, may experience symptom distress, and at the same time, are concerned 
about the impact on their everyday life, overall functioning or threats to their individual identity 
62
. A 
concept used in times of the chronic illness care paradigm, therefore, not only needs to allow for symp-
toms important for immediate and long-term health maintenance but also must consider the patient's per-
spective by integrating symptoms and dimensions that are potentially relevant to PLWHs' individual qual-
ity of life and well-being.  
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Symptom experience 
Symptom experience is defined as the "subjective experience reflecting changes in the biopsycho-
social functioning, sensations, or cognition of an individual" 
63
. Traditionally measured dimensions of 
symptom experience, based on the Common Sense model by Leventhal et al. (1992), refer to symptom 
severity/intensity and symptom frequency as the cognitive elements, and symptom distress as the emo-
tional component of symptom experience 
13,60
 and are explained in the next paragraph, followed by an 
exploration of instruments currently used to assess symptom experience and/or symptom distress.  
Symptom severity denotes the perceived seriousness of a symptom. In the literature, intensity has 
been a term used synonymously with seriousness. There is some evidence suggesting that symptom se-
verity/intensity inversely negatively correlates with quality of life dimensions 
64,65
 and adherence 
66,67
. 
Symptom frequency refers to how many times a specific symptom was experienced during a given 
time. From the literature on HIV, it appears to be the least studied dimension of symptom experience. 
Only one study was found reporting the relationship between symptom frequency and adherence. This 
study found that very frequently occurring symptoms was a barrier to adherence 
67
. Frequency and inten-
sity of HIV-related symptoms were found to be strongly positively correlated 
68
.  
Instruments used to assess symptom experience 
Instruments purporting to measure symptom experience often do not integrate the emotional compo-
nent, and although individual symptom experience is widely acknowledged as the basis to identify symp-
toms that need management, there is a great diversity of tools used to assess PLWHs' symptom experience. 
These tools comprise diverse and varying amounts of symptoms, often compiled on the basis of symptoms 
prevalent before the wide distribution of ART. Most instruments lack adaptation to currently experienced 
symptoms based on a patient-reported symptom pool. Symptoms that need management from a patient's 
individual perspective might, thus, not be identified 
69,70
. Moreover, instruments include varying symptom 
experience parameters in diverse combinations, i.e., symptom severity/intensity, and/or frequency, and/or 
distress/bother, however, these typically employed measures to query PLWH about their symptom experi-
ence are reductions of the concept of symptom management 
71
 and disregard other elements important to 
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lead a normal life with a chronic illness. This deficiency is passed on into clinical practice, and might be one 
reason why PLWHs' symptom experience does often not concur with the health care provider's assessment 
of the situation 
52,72,73
.  
Most often and internationally used instruments are the Memorial Symptom Assessment Scale in its 
full length and as short form (MSAS/MSAS-SF 
74,75
 and the Sign and Symptom Checklist for HIV patients, 
revised (SSC-HIVrev 
76
). The SSC-HIVrev is a comprehensive list of 72 signs and symptoms that could be 
experienced by PLWH complemented by a Likert-type scale asking about perceived symptom intensity. The 
authors differentiate between signs, which describe individually perceived changes in functioning, and 
symptoms, under which all changes perceptible by others are subsumed. Signs are not necessarily percepti-
ble by others, whereas symptoms are. The SSC-HIVrev is often complemented by a question relating to 
overall symptom distress as perceived by the patient. The MSAS (36 symptoms, frequency, severity, dis-
tress), and its short form, the MSAS-SF (36 symptoms, only frequency and distress of symptoms), was orig-
inally designed for patients with cancer. The MSAS-SF has first been used and validated in a HIV-positive 
sample in 1999
77
 and has been used to assess HIV-related symptoms since. In addition to the symptoms, this 
instrument encompasses the differentiated assessment of severity, frequency, and associated distress of each 
of the symptoms. No differentiation is made between signs and symptoms. Other symptom lists include 
symptoms as condensed from printed evidence 
78
, or physical assessment by a physician 
79
. Some symptom 
lists used before cART, e.g., the 14-item scale of signs and symptoms commonly associated with HIV ill-
ness 
80
, or the symptom inventory by Cleary et al (1993) 
81
, were also used after the life-saving changes in 
medical treatment 
64,82
. Justice et al. 
83
 developed a 20-item symptom index from existing knowledge on 
symptom frequency and bothersomeness.  
Evidence: symptom experience 
Symptom experience was mainly reported in relation to different domains of quality of life and ad-
herence to medical treatment. Both outcomes, quality of life in its diverse dimensions and adherence to 
medical treatment, were better with less 
9,77,79,84-96
, less severe 
65-67,90,97
, and less distressing or bothersome 
77,90,93,94,98-100
 symptoms as perceived by the patients. Evans et al (1998) found a negative correlation of 
symptom experience and life satisfaction 
101
.The experience of more 
102
 and more severe 
103
 symptoms, or 
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body image changes due to lipodystrophy was related to increased emotional distress and bother 
104
. 
Women and IV substance users seemed to report more and more severe symptoms than men or non-users 
105,106
. A further area of interest relating to symptom experience is the interplay between patients and pro-
viders relating to perceived symptoms: providers and patients seem to focus on different symptoms 
73,107
. 
The positive effect of patient-provider concordance in view of symptoms on adherence and overall func-
tioning was reported recently 
108
. Collaboratively reaching clarity on symptom definition and symptom 
weight 
109
 in addition to laboratory parameters 
70,82
 seems a promising way to improve concordance and 
achieve satisfactory patient-provider encounters. Moreover, considering the (sometimes diffuse) impact 
of living with HIV and symptoms on daily routine or social interactions 
81,110,111
 was recommended in 
order to properly assist PLWH.  
While, for instance, some symptoms and symptom parameters that are important for health care 
providers may have a limited immediate impact on patients' daily lives 
112
, others, such as appearance-
related symptoms 
113
, fatigue and sleep disorders 
114
, can severely interfere with the patient's every-day 
functioning and overall quality of life 
115
. Finding a common basis on which symptoms that need man-
agement are identified, i.e., what constitutes symptom experience, could have an impact on diverse out-
comes, as symptom experience has been linked to adherence 
89
, quality of life 
111
, and disease progression 
116,117
 in PLWH.  
Symptom distress  
Symptom distress is defined as the lived experience associated with mental and social suffering as a 
result of symptoms and refers to the emotional aspect of symptom experience. As conceptualized by Ridner 
118
, symptom distress delineates the unique discomfort or emotional state experienced by an individual in 
response to symptom occurrence or symptom management which results in harm to the person, either tem-
porary or permanent. Due to the diversity of concept uses, the authors suggested to use "psychological dis-
tress" instead of distress only, describing "patient discomfort related to symptoms"
118
. Distress seems to be 
used by nurses rather in the sense of bothersomeness, as is described in her conceptualization article. Some 
authors explicitly use bothersomeness associated with symptoms 
83,90,106
.   
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Instruments used to assess symptom distress 
In the scientific literature referring to symptom distress, the concept is operationalized in various 
ways and its use is manifold. Two main sets of used measurement tools can be roughly distinguished:  
 Distress is assessed as one dimension of symptom experience, as, e.g., in the MSAS / 
MSAS-SF 
75
. Each of perceived symptoms is assessed in view of its severi-
ty/frequency/associated distress. Distress is not further operationalized.  
 Distress is used as a correlate of symptom experience, and differentiated by assessing 
symptoms of depression, anxiety, or psychopathology representing distress (e.g., 
119-121
. 
For instance, the Symptom Check List SCL90-R 
122
, and its short form, the Brief symp-
tom inventory (BSI) 
119
 are often employed in symptom distress research, either to assess 
symptoms of distress in their own right or for correlations with, e.g., total number of 
symptoms. Both are tools to assess psychological distress by self-report and build upon 
53 questions physical and psychological symptoms grouped in 9 primary symptom di-
mensions as sources of psychological distress: somatization, obsessive-compulsive, inter-
personal sensitivity, depression, anxiety, hostility, phobic anxiety, paranoid ideation, and 
psychoticism. In addition, both, the SCL90-R and the BSI provide three summary scores 
for distress ("global indices"), namely the General Severity Index (GSI), the Positive 
Symptom Distress Index (PSDI), and the Positive Symptom Total (PST). The global indi-
ces are frequently used as representation of the subjectively perceived burden by (physi-
cal and psychological) symptoms of distress. 
As symptom manageability refers to the individually perceived symptom, it rather depicts symp-
tom-associated bother than psychopathology. We, therefore, focus on the first set of symptom distress 
measures. Although symptom distress is often used in direct relation to symptoms, its operationalization 
remains a challenge; and many authors do not provide a semantic definition of "symptom distress."  
In the used tools to assess distress due to symptoms, "symptom distress" is either incorporated as one 
of several dimensions representing symptom experience, or specifically assessed by employing a list of 
varying symptoms. Each of perceived symptoms is rated in terms of symptom experience dimensions, or 
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distress only. For instance, in the MSAS, to each symptom denoted as present during the prior week patients 
are asked to specify distress in addition to symptom severity and/or frequency. Most tools allow a distress 
summary score.  
Some questionnaires use a slightly different wording by assessing "bother" or "bothersomeness" (see 
the table "Instruments used to measure symptom experience"), thus focusing the PLWH's unique experience 
in terms of emotional burden due to symptoms. Mathews et al. (2000) and Crystal et al. (2000), for instance, 
both assess the bothersomeness of 14 HIV-related symptoms 
90,106,107
; Justice (1999) and Justice & Holmes 
(2001) 
83,107
 employ a list of 20 symptoms and includes 'bother' in addition to frequency of symptoms. Duran 
et al. (2001) and Carrieri et al (2003) use a tool that assesses the presence and distress of symptoms com-
piled on the basis of the various short-term side effects described in the literature 
78,88
. 
Evidence: symptom distress 
Symptom distress was found to be related to diverse outcomes, such as lower quality of life 
98,123-129
, 
adherence 
108,130-133
 or daily variations in mood 
134
.  
Self-management strategies to alleviate perceived symptoms include, for example, spiritual activity 
135
 distraction, or acupuncture 
136
. As spiritual activities increased, quality of life increased, distress of 
HIV-related stressors (functional impairment, work impairment, HIV-related symptoms) decreased.  
Distress or bother due to symptoms seems to be specific to population and illness. Symptom dis-
tress scales were invented for specific populations in specific situations, for example, the distress scale for 
cancer patients 
137,138
 or the physical symptom distress scale by Chiou (1998) 
139
, designed for patients 
with end-stage renal disease. Symptom bother, however, only in parts seems to be relating to ethnicity: in 
a recent publication, Regnault et al. provided evidence for the cross-cultural validity of the ACTG symp-
tom distress module, a list of 20 symptoms including a measure for symptom-associated bothersomeness 
of each perceived symptom 
83,140
 . Differential item functioning (DIF) was analyzed using logistic regres-
sion analysis and revealed statistically significant differences (0.001 threshold) between ethnic groups for 
only four symptoms, namely fatigue, headaches, fever, and anxiety. Bother due to headaches, for in-
stance, was significantly higher for Bantu patients than it was for the other ethnic groups, and fatigue 
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seemed to be more bothersome for English – speaking patients using the occidental-English version of the 
questionnaire than it was for patients responding to the Bantu, American Spanish and African Indo-
European versions of the questionnaire.  
Bothersomeness of symptoms refers to the worry, disturbance, or trouble related to a symptom as ex-
pressed by those concerned. Bothersome symptoms were found to relate to quality of life 
90,93,94,98
 and ad-
herence 
100
. Bothersomeness integrates the patients' individual perspective and denotes an emotion due to 
symptoms. Although a useful concept, is not systematically employed to identify symptoms that need man-
agement.  
SUMMARY  
In sum, symptom management issues are regularly discussed in medical follow-up appointments, 
however, despite the integration of patients' perspectives in symptom management negotiations, traditional-
ly used measures (i.e., symptom severity and frequency) to identify symptoms that need management do 
not seem to capture the patient's needs and, consequently, patients' expectations are frequently unmet 
141
. 
Although symptom frequency, symptom severity, and associated distress or bother are considered core 
indicators of the patient's individual experience of perceived symptoms 
13,60,75,142,143
, they do not truly cap-
ture the wholeness of PLWHs' lived experience associated with symptoms in the chronic phase of the HIV 
trajectory. Therefore, they only allow the identification of a limited number of symptoms that need man-
agement due to symptom expression and associated distress. Moreover, symptom lists that were invented 
before cART was widely available may not have been adapted to new symptom profiles, and are of limited 
value to capture symptoms of concern to patients in a chronic phase. Subjective illness theories, such as the 
Common sense Theory by Leventhal et al. (1992) support the assumption that objective measures may be 
of limited importance to patients, as illness perception is greatly determined by individual concepts and 
interpretations. Patients, according to this model, base the assessment of symptoms that need management 
not only on symptom expression, but rather on a combination of their own interpretation of perceived 
symptoms, illness representation (e.g., cause, time-line, control), personal (such as demographic and cul-
tural) factors, and social support. Moreover, these factors are mutually influential and individually 
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weighted. Symptom severity or frequency, thus, may or may not be the most important aspects when pa-
tients express concern about a symptom. Moreover, to our knowledge, there is no instrument or concept 
currently used which integrates dimensions of daily living with HIV to identify symptoms that need man-
agement in the chronic phase of HIV. The most promising approach to caring for patients with chronic 
diseases is to approach the illness as a collaborative endeavor, acknowledging the patient as an expert of his 
condition, living context, and emotional situation. Health care providers and patients not only exchange 
information but also are partners for negotiating approaches to symptom self-management in every-day 
life. Comparing the parameters used to identify symptoms that need management and those important for 
patient self-management in daily life, it becomes clear that the patient perspective on consequences of a 
symptom for daily life are often neglected. 
In order to assess a patient's unique and individual perception of symptoms that need management, 
and in the future, the success of symptom management interventions, we therefore propose to use a meas-
ure representing this individuality and uniqueness. As in clinical encounters, patients often describe their 
life with symptoms using sentences like "I can't manage symptom x or y anymore", or "well, yes, symp-
toms are well manageable," thus directly referring to their ability to influence the impact of the symptoms 
on their life, we suggest "perceived symptom manageability" to meet this condition: the patient is the only 
person who is able to assess the perceived manageability of a symptom in the context of his or her lived 
experience.  
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AIMS OF THE PROJECT 
The changes asked from the health care system to care for a growing number of people with chron-
ic illnesses, among which are PLWH, also call for a new interpretation of symptoms that need manage-
ment and might warrant the adaption of instruments to the new paradigm. We propose "perceived symp-
tom manageability" as a concept holding promise to provide common ground for identifying and negotiat-
ing symptoms that need management by its broad perspective on a life with symptoms. Before it can be 
presented to clinical practice and research as a useful concept, however, its in-depth exploration is war-
ranted. Therefore, the aims of this dissertation study were to develop a theoretical definition of the con-
cept, and explore its constituents. Moreover, the association with symptom experience parameters com-
monly used to identify symptoms that need management and the relation of relating concepts as depicted 
in a theoretical framework is explored.  
DETAILED RESEARCH QUESTIONS  
In order to achieve these aims, we followed the procedural steps of concept synthesis 
144
 using a 
mixed method approach to answer the following research questions:  
 How can "perceived symptom manageability" be preliminarily defined and 
 What elements are important for PLWH regarding perceived symptom manageability? 
 What are the most/least manageable symptoms in the sample and how does "manageabil-
ity" relate to known symptom experience parameters and influencing factors proposed in 
the model presented by Spirig et al. (2005)? 
METHODS OF THE PROJECT 
Design. The research project presented in this thesis was designed and proposed as a descriptive 
exploratory cross-sectional investigation, using existing data of a larger, multi-center project exploring 
symptom experience of PLWH. Our study team conducted the Symptoms and other Life Experiences and 
Adherence (SOLEXA) from 2003 to 2006 
145
. The SOLEXA study integrates relationships between 
symptom experience, symptom manageability, adherence, health-related quality of life, and disease pro-
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gression from the patients and their close support persons' perspective. The SOLEXA study was estab-
lished in close collaboration with four of the seven centers enrolled in the Swiss HIV Cohort Study 
(SHCS), an ongoing multi-center cohort study project established in 1988 and focusing on patient orient-
ed HIV research. In order to allocate resources in a focused manner, questionnaires were solely translated 
into German, with the consequence, that the investigation only was possible in centers where the prevail-
ing language was German, i.e., Zürich, Basel, Berne, and St. Gallen.  
Methodology and procedure. For the PhD project, as for the main study, a mixed methods triangula-
tion design 
146
 (see figure below) was used to follow the procedural steps of concept synthesis 
144
. More 
specifically, based on a wide variety of uses of the concept, a working definition was elaborated. To verify 
and modify the definition and to further elaborate the concept's constituents, qualitative, and quantitative 
methods were used. All steps were taken purposefully to develop the concept's constituents and definition. 
Philosophically, thus, our guiding worldview was pragmatism: qualitative and quantitative approaches 
were used with the focus on our overall aim, rather than on the methods 
147
. Using qualitative as well as 
quantitative techniques to collect and analyze data, the often limited view of a single approach was 
diminished by facilitating a more comprehensive view and increasing understanding the “perceived symp-
tom manageability” concept from different, yet complementary perspectives. Using a triangulation design, 
which requires convergence of qualitative and quantitative results, allowed us to bring together the 
strengths of both methods 
148
, that is, large sample size, generalization (“outside view”), detailed descrip-
tion, and in depth exploration (“inside view”), taking advantage of the complementarity of the qualitative 
and the quantitative perspective 
149
. To allow transparency in view of the processes used to combine find-
ings from the different analyses and methods (integration), we developed triangulation protocols depicting 
the steps taken 
150
. A first protocol sheds light on the integration process in view of modifying and verify-
ing the definition of the concept; a second protocol was elaborated to compare and contrast symptoms 
mentioned in qualitative interviews and manageability of these symptoms as explored in the quantitative 
analysis. Using multiple methods helped to achieve a valid, although preliminary, conceptual definition of 
perceived symptom manageability, because it allowed us to complement quantitative findings with 
meaning and, thus, enhance the interpretability of quantitative study results by allowing insight into a 
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patient's qualitative perception of symptom manageability. Moreover, it assisted the recognition of main 
findings discussed in Chapter 7.  
The research project was conducted in four phases, the first and third of which comprised separate, 
independent analyses. More specifically, in phase 1, a new use of the known concept “manageability” was 
defined and a working definition of “perceived symptom manageability” was suggested. Analysis 1 synthe-
sizes the broad range of uses of manageability” and interprets the concept in view of symptoms. Based on a 
broad literature search, a concept synthesis was conducted and a working definition of the specific use “per-
ceived symptom manageability” was developed, following the first procedural steps of a concept synthesis 
according to Walker and Avant 
144
 (analysis 1, concept synthesis). 
In a second phase, the qualitative analysis of narrative interview data allowed insight into elements 
of “perceived symptom manageability” from the patients' perspective. Dimensions rendering a symptom 
more or less manageable were identified. Analysis 2 addresses the issue of perceived manageability di-
mensions as used by patients: By listening to patients, the concept “perceived manageability” was identi-
fied as potentially promising to identify symptoms that need management from the patients' perspective, 
and from narrative interviews, elements contributing to symptom manageability were inductively ex-
plored 
151
.  Furthermore, the preliminary working definition from analysis 1 was refined. 
In a third phase, the concept was explored in relation to a theoretical model of symptom manage-
ment in persons living with HIV
13
; and analysis 3 addresses this relation by employing bivariate and mul-
tivariate analysis. The integration of findings, the fourth phase, is described in Chapter 6. 
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Graphic 1: Overview of the mixed methods dissertation project 
 
 
 
 
 
 
This thesis is divided into seven chapters. Chapter 1 provides a literature-based rationale for the introduction of 
an integrative measure to identify symptoms that need management based on PLWHs' living context and health care 
premises. Chapter 2 describes the aims of the research program. The next three chapters incorporate the publications. 
Chapter 3 presents the synthesis of “perceived symptom manageability,” the description of a new use of the well-
known “manageability” concept, titled “I can't manage symptoms anymore” - Perceived symptom manageability, the 
synthesis of a new use of a known concept. This article appeared in the Journal of Advanced Nursing. Chapter 4 fea-
tures "“You need to manage, you know:” Long-term HIV survivors' perception of symptom manageability: The inte-
gration of lived experience into a theoretically developed concept." This article summarizes the results of the qualita-
tive exploration of 13 qualitative interviews and has been submitted to The Scandinavian Journal of Caring Sciences. 
Chapter 5 presents the publication “Symptom manageability in Swiss HIV-infected Patients.” This article focuses on 
the quantitative exploration of “perceived symptom manageability” in relation to parameters suggested by Spirig et 
al. (2005) in their theoretical model of symptom management in people living with HIV. In Chapter 6, findings of the 
three analyses are discussed as one entity, and Chapter 7 contains the discussion of key findings. Finally, suggestions 
for further research and clinical implementations are provided. 
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ABSTRACT  
Aim: This paper is a report of the synthesis of the concept of perceived symptom manageability. 
Background: Common symptom assessment parameters fail to address concerns about the impact 
of symptoms on everyday life, overall functioning, or threats to individuals living with the human immu-
nodeficiency virus. We claim that the concept of ‘perceived symptom manageability’ integrates these 
important dimensions of the patients’ experience of their symptoms.  
Data sources: Online databases, thesauri and dictionaries were accessed in January 2012. A free 
search was performed scanning the PubMed, CINAHL and PsycINFO databases for entries from 2001–
2011 using ‘manageability’ in the title or abstract as a search term. 
Review methods: We followed the steps delineated by Walker and Avant for concept synthesis. 
Uses of the concept ‘manageability’ were identified, listed, meaningful usage clusters were generated and 
a preliminary working definition was created.  
Results: Social resources and individual interpretation were relevant in view of managing a diffi-
cult situation, thus positioning ‘manageability’ in a social and interpretational context that exceeded ob-
jective control. We preliminarily defined perceived symptom manageability as ‘the extent of the per-
ceived ability to bring social and personal resources into play to successfully deal with or control symp-
toms, despite difficulties’.  
Conclusion: We believe that our working definition represents a promising start to understand and 
address the manageability problems that individual patients face regarding particular symptoms and may 
serve as a basis to not only identify symptoms but also areas of intervention that are of most concern to 
individual patients. 
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SUMMARY STATEMENT 
What is already known about this topic 
 Persons living with the human immunodeficiency virus (HIV) can be confronted with burdensome 
symptoms due to the illness itself, medication side effects and co-morbid conditions.  
 Symptoms needing management in persons living with HIV are identified using parameters ex-
ploring the expression of symptoms, e.g. frequency, severity/intensity and bother/distress. 
 Although patients often use the expression ‘I manage well (not well)’ when asked about their life 
with symptoms, the concept of ‘perceived symptom manageability’ has not yet been explored. 
What this paper adds 
 The concept of ‘manageability’ has been used generically and specifically, but not with regard to 
symptoms; however, manageability is a concept that can be used with symptoms.  
 Manageability of health challenges is consistently associated with the availability of a supportive so-
cial environment and the use of personal resources.  
 A working definition of ‘perceived symptom manageability’, based on an open internet search and 
concept synthesis, i.e. the extent of the perceived ability to bring social and personal resources into 
play to successfully deal with/control symptoms, despite difficulties.  
Implications for practice and/or policy 
 ‘Perceived symptom manageability’ represents a promising complement to the parameters 
commonly used to identify symptoms needing management, but should not be used without in-
quiring the patients’ interpretation of the concept.  
 Further research exploring attributes of perceived symptom manageability from the patients’ 
perspective is needed to substantiate or refine the working definition.  
 Inquiring the patients’ perception of symptom manageability may elicit concerns not captured by 
commonly used parameters assessing symptom severity (intensity) and frequency and facilitate 
satisfactory and more effective patient- provider interactions.  
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INTRODUCTION 
In countries where antiretroviral therapy is available and affordable, human immunodeficiency vi-
rus (HIV) is acknowledged as a chronic illness. As with many other chronically ill populations, persons 
living with human immunodeficiency virus (PLWH) can be challenged by a host of symptoms due to 
comorbidities, the illness itself and the side effects of medications in the course of their illness trajectory. 
Identifying symptoms that need management from the patients’ perspective is, thus, an integral part of 
clinical follow-up visits in any social or political context. In a research project conducted to better under-
stand the mechanisms underlying the symptoms and medication management of PLWH 
1
, we realised that 
the ability to manage symptoms in their daily routine is of great importance to this population and that 
this perceived manageability of symptoms is crucial to the overall experience of symptoms by PLWH. 
We also realised that the symptom experience parameters commonly used by providers to identify symp-
toms needing management, i.e. symptom frequency and severity/intensity, bother, or distress, failure to 
address the concerns of PLWH about integrating their symptoms into everyday life and overall function-
ing 
2,3
. Disagreement on symptoms needing management may occur 
4,5
. Therefore, we postulate that the 
parameters used to identify symptoms needing management ought to incorporate the individual interpre-
tation of PLWH related to their daily living with symptoms and propose ‘perceived symptom manageabil-
ity’ to be such a term. To our knowledge, the term ‘manageability’ has not been described or used in the 
context of symptoms to date; therefore, an exploration and description of the concept are needed. Our aim 
was to explore ‘perceived symptom manageability’ and establish a working definition of this concept.  
BACKGROUND 
Since the collaboration between PLWH and healthcare providers has become a core issue in health 
care encounters and is particularly important in the field of HIV care 
6
, we conducted a mixed methods 
research project 
1
 in an effort to better understand the collaboration between providers and patients in 
view of medication and symptom management. We based our thinking on the Common Sense Model 
(CSM) of Leventhal et al. 
7
 and specifically on its adaptation for PLWH suggested by Spirig et al. 
8
, 
which provides an advanced framework for the care of PLWH. While conducting interviews for this pro-
ject, we discovered that PLWH are actively involved in designing and negotiating symptom management 
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strategies; however, patients and healthcare providers do not always agree on the symptoms needing 
management 
4,5
. This divergence may impede effective illness management and diminish the quality of 
the health care encounter 
9
.  
To understand potential sources of disagreement in view of the symptoms needing management, sub-
jective illness theories such as the CSM 
10,11
 and specifically its adaptation by Spirig et al. 
8
, are useful 
frameworks. These theories underscore the individuality inherent in the interpretation of an illness and its 
symptoms. In the CSM, Leventhal et al. 
10,11
 state that first, internal and external stimuli generate an indi-
vidual, cognitive representation of the problem and emotions. Emotions and representation are cues that lead 
to separate, yet intertwined, coping actions and the evaluation of outcomes in both dimensions, which feed 
back into representations and generate further emotions; finally representing a self-regulatory system. Both 
processing tracks, i.e. the emotional and the cognitive, are influenced by self and the social context. To un-
derstand the drivers of patient behaviour, it is crucial for health care providers to be aware of a patient’s 
illness representation, which, in turn, shapes their actions to confront the illness and form the basis for out-
come interpretation. Disagreements may occur within the attributes of illness representation, i.e. identity, 
time-line, consequences (physical, social and economic), antecedent causes and the potential for cure and/or 
control of a threat. Furthermore, according to the authors, diverging notions of problem space (i.e. the repre-
sentation-coping-evaluation pathways), culturally diverging interpretations of the illness, or inconsistencies 
with an individual’s personality may result in divergence between patients and providers regarding treat-
ment. In fact, the lay interpretation of the cause, effect and controllability of an illness or symptom deter-
mines how people react to the threat and cope with the unpleasant situation 
7
. As the self-regulatory system 
is coherent in itself and consistent for an individual patient, it is crucial that providers are aware that a pa-
tient’s interpretations of their emotional and cognitive representation-coping-evaluation pathways (i.e. the 
patient’s problem space) may differ from state-of-the art interpretations and cannot be altered without ac-
knowledging its consistency for the patient. 
For PLWH, social support has been established as being crucial to successful symptom and illness 
management 
8
 and was integrated as a core determinant for successful symptom management by these 
authors into the CSM. Furthermore, symptom manageability was introduced as a variable representing the 
cognitive and emotional evaluation of individual symptom management endeavours by addressing the 
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overall success of these actions as perceived by the patient, which will, eventually, impact further actions, 
health-related quality of life, clinical parameters and adherence. 
We suggest that discrepancies between providers and PLWH about symptoms needing manage-
ment occur due to their different perspectives when evaluating symptom management outcomes. PLWH 
and providers are both concerned about identifying those symptoms that need management and to initiate 
management actions and a reduction of symptom severity (intensity) and their frequency of occurrence is 
commonly interpreted as management success. However, this perspective fails to address the challenges 
posed by the symptoms 
2, which are subject to the patient’s individual evaluation. In a recent study inves-
tigating adherence and attitudes towards haemodialysis in patients with end-stage renal disease, Karolich 
et al. 
12
 found that the subjective meaning attributed to the illness greatly influenced how patients under-
stand and manage their chronic condition. Furthermore, there is evidence that interventions based on a 
patient’s illness representation can successfully promote their well-being 13 and adherence to medication 
14. Integrating a concept that addresses a patient’s lived experience of managing their symptom(s) in addi-
tion to ‘objective’ criteria to identify symptoms needing management may contribute to mutual under-
standing and improved satisfaction with the health care encounter 
9
. On the basis of our clinical observa-
tion that PLWH often use ‘manageable’ when describing their symptoms, we considered ‘perceived 
symptom manageability’ as a concept that expands the focus of symptom assessment from mere symptom 
expression to a comprehensive understanding of the problem space perceived by PLWH, as depicted by 
Spirig et al. 
8
.  
DATA SOURCES 
If a concept is already used, but not described in a specific area or context, concept synthesis is 
deemed especially useful 
15
. By exploring broadly as many current uses of a concept as possible, summa-
rising core aspects of the concept and translating it to a new area of use may add a new perspective to this 
specific area. According to these authors, concept synthesis precedes the well-known approach of concept 
analysis, which is used if a concept is common knowledge, has been used in different areas in many situa-
tions, became blurred, or needs sharpening. Concept synthesis also complements the process of concept 
derivation, where a concept is transferred from one domain to another where it has not yet been used (e.g. 
PERCEIVED HIV SYMPTOM MANAGEABILITY | 61 
 
from industry to nursing). To expand and target the use of ‘manageability’ to HIV symptoms and to pre-
liminarily define ‘perceived symptom manageability’, we employed concept synthesis as described by 
Walker and Avant 
15
. 
Our concept synthesis is based on online data sources. The steps to perform concept synthesis, as 
described by Walker and Avant (2005) and how the steps were followed, are summarised in Table 1.  
As a first step in concept synthesis and to achieve familiarity with the topic, Walker and Avant 
15
 
suggest the use of all possible sources of information to detect as many current uses of the concept as 
possible. Our sources were PubMed, CINAHL, PsycINFO (entries within the last 10 years (2001–2011), 
‘manageability’ in the title or abstract); the Google search engine (entries within 24 months; search term 
‘manageability’ in the title) and online versions of dictionaries and thesauri which were scanned using the 
search terms ‘to manage’, ‘manageability’, ‘ability’ and ‘manageable’ (Table 1). To allow a broad per-
spective on concept use, the search was not limited to any area of use. 
Table 1. Steps of the Concept Synthesis 
Steps described by  
Walker and Avant 
15
 
Data source Action Process 
Step 1:  
achieve familiarity  
with the topic;  
identify current uses of 
the concept 
Online versions of thesauri  
and dictionaries  
Search term: 
‘to manage’, ‘manageability’, 
‘ability’ and ‘manageable’   
 
PubMed, Cinahl and PsycINFO 
Search term: ‘manageability 
[Title and Abstract]’ 
 
Google search engine Search term: ‘manageability’ 
Results of step 1 
inform step 2 
Step 2:  
list and combine uses  
of the concept  
Results from step 1:  
abstracts and definitions 
Clustering of uses listed in 
dictionaries and thesaurus; 
reviewing abstracts, listing of 
uses of manageability in ab-
stracts and clustering of ab-
stracts presenting similar uses 
Results of step 2 
inform the definition 
of the new use 
Steps 3a and 3b:  
definition of the new use 
Reduced uses  
(results from step 2)  
Summarising meaning of man-
ageability within semantic 
clusters; transfer of uses to 
symptoms and creation of the 
preliminary working definition 
 
In a second step, we listed the uses of ‘manageability’, ‘to manage’ and ‘manageable’ as retrieved 
from online thesauri and dictionaries. Similar uses were grouped and same uses were discarded. Abstracts 
retrieved from online databases (PubMed, CINAHL and PsycINFO) were scanned for the use of ‘managea-
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bility’ and emerging groups of uses were compared with the categories identified in online thesauri and 
dictionaries and assigned accordingly. .Abstracts were then scanned in each semantic group and included in 
our synthesis if the use of ‘manageability’ provided information on the meaning of the concept from a per-
son’s/patient’s perspective if the use of the concept was either related to health or a condition, or was trans-
ferable to the health context. The meaning of manageability was summarised in each group of uses. 
To extend the information on the uses of the concept to non-scientific sources, the Google search 
engine was employed and citations were scanned for additional uses of the concept. In the next step, we 
combined the core information from summarised evidence and a working definition of the use of the con-
cept with symptoms was created.  
RESULTS 
Steps 1 and 2: Achieve familiarity with the topic and identify current uses  
 of the concept; list the uses and combine them into meaningful clusters  
Online versions of English dictionaries and a thesaurus 
We accessed 4 different online dictionaries and one thesaurus: Wiktionary 
(http://en.wiktionary.org/wiki/Manage; http://en.wiktionary.org/wiki/manageability), Merriam-Webster 
Online Dictionary (http://www.merriam-webster.com/dictionary), Merriam-Webster Online Thesaurus 
(http://www.merriam-webster.com/thesaurus), Oxford English Dictionary (http://www.oed.com) and 
Houghton-Mifflin Online Dictionary (http://ahdictionary.com/word/search.html): All electronic sources 
were accessed on 2 January 2012. ‘Manageability’, was referred to as ‘the quality or condition of being 
manageable’ (http://www.oed.com) and not further discussed in any of the sources as a noun. Therefore, we 
performed all further steps using the descriptions of ‘to manage’, mainly described as a transitive verb with 
some intransitive uses (Table 2). Uses were summarised into 4 broad semantic categories: ‘to act as a man-
ager’, ‘to control the movements or actions of something (tool)’, ‘to exert one’s authority: control someone 
(animal or human)’ and ‘to succeed in accomplishing or achieving, especially with difficulty’ (Table 2). As 
the only source to do so, the Oxford English Dictionary listed the specific use of ‘to manage’ in the health 
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care setting as follows: ‘to control or relieve (a disease or disorder); to look after (a patient, case, or client) 
as appropriate. Also especially in later use: to provide or coordinate (a suitable course of action for the care 
of such a person)’ (http://www.oed.com). 
Literature search PubMed (National Library of Medicine), CINAHL and PsycINFO 
The literature search of PubMed, CINAHL and PsycINFO was performed for the years 2001–2011 
with ‘manageability’ in the title or abstract. A total of 320 abstracts were listed, of which 86 were identified 
as duplicates and were discarded, resulting in 334 abstracts for closer inspection. Six citations were addi-
tionally discarded because ‘manageability’ was not in their title or abstract. Finally, 228 abstracts were 
checked for the use of the term ‘manageability’ and clustered according to the use of this term.  
Table 2 provides an overview on the combined uses of the concept in dictionaries and the assign-
ment of abstracts retrieved from PubMed, CINAHL and PsycINFO  
Open internet search using the Google search engine  
The Google search returned 777 links when ‘manageability’ was entered. These were compatible 
with the already discovered uses and no new uses were detected.  
Step 3a: Review and summarise the uses  
The uses of ‘manageability’ in the abstracts basically represented the substantiated transitive uses of 
‘to manage’ listed in the online thesaurus and dictionaries and ‘manageability’ as part of the sense of coher-
ence (SOC) (Table 2). Finally, 21 articles corresponded to the inclusion criteria for the concept synthesis 
and represented a patient/person experience in the health care setting or experiences that were transferable to 
this setting. Four articles referred to the use of the concept as part of a scale. Only one study group included 
PLWH 
16,17
. The following paragraphs provide a summary of concept uses in semantic clusters. 
 
 
Table 2. Step 2: listing and combining the uses of the concept in dictionaries, assignment of clustered abstracts and articles integrated in synthesis 
1Wiktionary; 2Houghton-Mifflin Online Dictionary; 3Merriam-Webster Online Thesaurus; 4Merriam-Webster’s Learner’s Dictionary; 5Merriam-Webster Online Dictionary; 6Oxford English Dictionary  
Transitive uses Categories of ‘manageability’ 
use listed in dictionaries   
Search results: clustered abstracts  
(number of abstracts) 
Articles integrated in the working definition, 
reporting perceived manageability  
To direct affairs or interests, be in charge of (manage a compa-
ny)1,2  
To look after and make decisions about3. Also: to handle or direct 
with a degree of skill4  
To conduct, carry on, supervise, control3,6 
‘Act as manager’ 
IT and e-learning (9)  Services (11)  
Project (5)   Hair (8) 
Processes, non-medical (5) 
- 
Risk (12) 
Eklof 2002, Peters-Guarin et al. 2012, Sanne 2008, 
Stave et al. 2006 
Medical processes (24) 
Arapakis et al. 2005, Bergk et al. 2004, Perioli et al. 
2009  
Occupational demands (8) - 
To handle, wield (a tool, weapon)1 
To direct or control the use of, handle (a machine tool)2 
To control the movements or actions of (something) (= control)5  
To handle, wield, or make use of6 
To control the movements or actions of 
something (tool);  
Material for clinical use (10) 
Medical device (7) 
- 
- 
To make submissive to one’s authority, discipline, or persuasion2 
To control the behaviour of (a child or animal)2,6  
To train or direct6 
To exert one’s authority: control some-
one (animal or human) 
Trait in children (9) Disabled persons (1) 
Prisoners (3) Horses (5) 
Workers (1) Other (2) 
- 
To handle or control (a situation or job)1 
To succeed in doing, accomplishing, or achieving something, 
especially with difficulty; contrive or arrange2,5 
To deal or cope with (something) usually skilfully or efficiently 
(managed the crisis)3,6 
With infinitive: to be successful or skilful enough to do some-
thing, usually with difficulty or in the face of adversity6  
To succeed in accomplishing or achiev-
ing, especially with difficulty 
Condition, situation, illness (29) 
Johansson et al. 2007, Karolich & Ford 2010, 
Olsson Ozanne et al. 2011, Power et al. 2010, 
Sunvisson & Ekman 2001, Wiklund 2008  
SOC (75) 
Structure: Bernabe et al. 2009, Bengtsson-Tops et 
al. 2005, Zimprich et al. 2006, Flensborg-Madsen 
et al. 2005, 2006 
Patients with specific conditions: Jensen 2001, 
Malterud & Hollnagel 2004, Nyman et al. 2011, 
Strang & Strang 2001 
Use in scale (4) 
Antonovsky 1987; Kennedy et al. 2009; Vinenzi et 
al. 2009; Reece et al. 2010, Hollub et al. 2011. 
 Total  228  
Intransitive uses   
To meet one’s day-to-day needs3  
To be able to live or to do what is needed by using what you 
have even though you do not have much5 
To cope or get by; to contrive to get on with something which is 
barely adequate6 
To succeed (despite difficulties) in accomplishing a task6 
Intransitive use 
To continue to get along; carry on 
There were no intransitive uses in the cited abstracts 
 ‘To act as a manager’ 
From 2 subgroups of this cluster, i.e. risk management and management of medical processes, we 
extracted qualitative information that could be transferable to our envisioned use of ‘manageability’.  
Risk management: The authors investigating the risk-taking behaviour of fishermen 
18
 and farmers 
19
 
and found that the interviewees engaged in preventive actions (safety work) if they perceived the managea-
bility of a risk as low. The finding was that the interviewees generally underestimated the risk or overesti-
mated their ability to manage such a threat. After group interventions, both groups perceived risks as less 
manageable. In another qualitative study, communities in the Philippines were questioned about their per-
ception of flood hazards. Communities perceived the manageability of a flood hazard in relation to the 
community’s capacity and available coping mechanisms 20. In a study on the risk-taking behaviour of rail-
way workers, Sanne et al. 
21
 found that risk-taking was not only related to the workers’ appraisal of risk 
manageability but also their duty to provide a functioning railway to the public. 
Manageability in medical processes comprised user-friendliness, as viewed by the researchers, such 
as non-invasive, frameless and self-adhesive for an X-ray surgery procedure 
22
. Bergk et al. 
23
 found, in a 
quantitative study, that the frequency and severity of drug interactions may not be adequate dimensions to 
assess the potential risk/harm. The authors state that measuring potential outcomes irrespective of their 
manageability may overestimate the risk arising from drug interactions. 
In sum, manageability of a risk or threat, as applied to studies of fishermen, railway workers and 
farmers, was the perceived ability to deal or cope with a difficult situation. However, the concept was 
connected to influencing factors such as personal values and social desirability. Moreover, solely 
weighting the quantifiable expression of an occurrence may underestimate the role of manageability. Pro-
cedure manageability was used in the sense of user-friendliness as viewed by non-patients. 
The semantic clusters ‘to control the movements or actions of something (tool)’ and ‘to exert one’s 
authority: control someone (animal or human)’ did not provide relevant information for our purpose.  
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‘To succeed in accomplishing or achieving, especially with difficulty’ 
Under this group of concept uses we assigned articles that were related to dealing with an illness, 
condition, or difficult situation. For patients living with amyotrophic lateral sclerosis, the constant fluc-
tuation between opportunities and limitations in an individual’s abilities made managing the life situation 
challenging and difficult 
24
. Creating a new frame of reference for interpreting life facilitated the manage-
ability of the illness and for these patients, comprised developing one’s own strategies to accept the situa-
tion, living in the present and the felt presence and assistance from a supportive network and authorities. 
For people living with a substance use disorder, manageability of their situation was supported by experi-
encing coherence in their life, confirmation and acceptance, as well as gaining a sense of community and 
attachment 
25
. Connectedness and interactions with a social network were also fundamental for patients 
with myocardial infarction to manage their situation 
26
. Being part of a social context and meeting ade-
quate physical challenges were important factors supporting the perceived manageability of the illness 
situation in patients with Parkinson’s disease 27. 
In sum, perceiving symptoms may be experienced as challenging and the main factors supporting 
the perceived manageability of the situation were connectedness, functional relationships and interaction 
with the social environment. Furthermore, the ability to constantly develop strategies to adapt to the fluc-
tuating and unpredictable physical and mental changes due to a chronic illness emphasised the volatility 
and difficulty of the situation.  
Use of ‘manageability’ as part of questionnaires 
There were 4 questionnaires distinctly employing the concept: The Orientation to Life Question-
naire 
28
, The Perceived Manageability Scale (PMnac) 
29
, the Multi-factor Attitude Towards Condoms 
Scale (MFACS) 
16,17
 and the HIV-Symptom Manageability Scale (HIV-SMS) 
30
. 
The Orientation to Life Questionnaire was developed to measure the sense of coherence, which 
represents an individual’s global attitude towards life and basically describes what keeps people healthy 
in a hostile environment. The SOC encompasses 3 explanatory concepts: making sense of what is going 
on (meaningfulness), understanding (comprehensibility) and manageability, which is defined as ‘the ex-
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tent to which one perceives that resources are at one’s disposal which are adequate to meet the demands 
posed by the stimuli that bombard one’ (Antonovsky 1987, p. 17). This global definition of manageability 
refers to life in general and remains abstract. In the questionnaire, manageability was operationalised as 
the perceived ability to trust in oneself, trust in others and act and control or overcome an unpleasant situ-
ation. The Orientation to Life Questionnaire has been employed and evaluated in diverse healthcare con-
texts and countries for many years 
31-33
. Validity evidence in terms of the structure of the questionnaire, 
however, is inconclusive. The 3-factor structure, as suggested by Antonovsky, has been examined by 
numerous authors: in the Finnish general population, a 1-factor solution seemed the most adequate 
34
; 
while in patients with schizophrenia, a 4-factor solution emerged 
35
. Zimprich et al. 
36
 explored 1107 
Swiss students, for which a 2-factor solution was found, combining ‘manageability’ and ‘comprehensibil-
ity’. While the construct ‘sense of coherence’ and the 3 components of comprehensibility, manageability 
and meaningfulness are well accepted, the operationalisation of the construct has been criticised and an 
adaptation of scale items was suggested 
37,38
.  
Perceived manageability in the SOC: Patients with chronic fatigue syndrome described their lives 
as increasingly chaotic, with lower manageability, comprehensibility, or meaningfulness scores than per-
sons diagnosed with other chronic illnesses 
39
. Patients newly diagnosed with a brain tumour reported that 
they achieved manageability by actively seeking social support and information. Despite their insecure 
situation, these patients constructed comprehensibility mainly by their own theories and thoughts 
40
. Feel-
ing part of the care process and having personal and social resources at one’s disposal facilitated coping 
with health problems among patients attending a general practice or persons with substance use disorder 
41,42
. In sum, although the kind of support may differ between populations, creating a new frame of refer-
ence to interpret life, the experience of coherence in life and being embedded in a community were ele-
ments contributing to the perception of manageability for all groups. The PMnac was developed by Ken-
nedy et al. 
29
 and based on Antonovsky’s concept to assess the manageability of spinal cord injury, em-
phasising (successful) control as the core dimension of manageability.  
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The HIV-SMS 
30
 encompasses a list of 82 HIV-specific symptoms, medication side effects and non-
specific symptoms that occur frequently in PLWH. To assess their perceived ability to manage a specific 
symptom, the participants were asked to rate their perception of symptom manageability for each symptom 
that occurred during the prior week on a Likert-type scale that provided options from 1, very poorly, to 6, 
very well. However, there was no information on the definition of perceived symptom manageability used 
in the scale. The scale was piloted a few years ago and preliminary validity evidence on the response pro-
cess and test content was established, the generation of further validity evidence is underway. 
The MFACS 
16,17
 was developed to fill a gap in previous research on condom use, which had been 
conducted for specific contexts or outcomes, e.g. preventing a pregnancy or the transmission of a disease. 
The MFACS specifically measures condom use. It encompasses 3 dimensions and covers cognitive and 
emotional aspects: perceived effectiveness, affective issues and manageability. Condom manageability 
not only refers to the actual handling of condoms, but also addresses less clearly defined issues such as 
dealing with embarrassment and being a difficult topic between sex partners.  
Step 3b: Creation of the working definition  
The group of uses listed in dictionaries and the thesaurus, ‘achievement of something despite diffi-
culties’ or ‘coming to terms/dealing successfully with difficult situations’ where a focused, skilfully per-
formed activity with the ultimate goal of success was described, allowed the application of the concept to 
symptoms. Symptom manageability, thus, could then be summarised as ‘the ability to successfully handle 
or deal with symptoms with a degree of skill’. 
Uses of the concept identified in empirical evidence across diverse populations emphasised the im-
portance of connectedness with a supportive network as a resource to deal with a condition or a difficult 
situation. Moreover, the evidence supported the individuality of the frame of reference providing the basis 
to evaluate the manageability of a situation and the notion that personal strategies to meet a constantly 
changing condition influenced its perceived manageability.  
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The inspection of questionnaires using the concept accentuates the relevance of ‘being in control’ 
of a condition or illness situation 
29
 and the importance of emotions and cognition 
16,17
. The generic and 
abstract formulation of Antonovsky’s 28 definition of manageability presented above allows the concept to 
be concretised for its use with symptoms. Therefore, ‘the extent to which one perceives that resources are 
at one’s disposal which are adequate to meet the demands posed by the stimuli that bombard one’ (An-
tonovsky 1987, p. 17), served as the basis for our working definition. The uses of the concept in diverse 
realms revealed that the activation of social and personal resources contributed substantially to the per-
ceived manageability of a complex situation. By integrating these aspects, our working definition of ‘per-
ceived HIV symptom manageability’ unfolds as follows: 
The extent of the perceived ability to bring social and personal resources into play to successfully 
deal with/ control symptoms, despite difficulties. 
DISCUSSION 
There are limitations to the present study. In the almost complete absence of evidence relating to 
‘manageability’ in PLWH, the transfer of ‘manageability’ to symptoms perceived by PLWH was based 
on evidence from other chronically ill populations, even from areas that were not related to symptoms or 
illnesses. Moreover, aspects contributing to the manageability of a challenging situation were investigated 
in relation to illnesses, but not to symptoms. Thus, its adaptation to symptoms involves a certain degree of 
insecurity and interpretation. The working definition is preliminary and needs further exploration. As it 
was developed theoretically, it may be incomplete; therefore, the interpretation of the concept by PLWH 
and the verification of the definition relating to symptoms in this population are important next steps. 
Further work needs to be done to relate the value and position of perceived symptom manageability in the 
broader conceptual model, integrating contextual and outcome variables such as quality of life, adherence 
and social support, as conceptualised by Spirig et al. 
8
. 
We undertook this concept synthesis because we realised that the concerns of PLWH in view of liv-
ing with symptoms go beyond alleviation and that commonly used parameters to measure management 
success do not sufficiently capture the patients’ perspective in view of integrating symptoms into a daily 
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routine and maintaining a normal life. Our working definition of ‘perceived symptom manageability’ clearly 
exceeds symptom management, which represents a provider view 
43
, by focusing on symptom control as 
measured by the severity and frequency of symptoms. ‘Deal with’, as formulated in our working definition, 
explicitly integrates the possibility not only to be ‘in control of’ symptoms but also to negotiate, handle, 
cope with, or learn to live with symptoms. PLWH often perceive symptoms as fluctuating and unpredicta-
ble, creating difficult situations that require a high degree of flexibility from PLWH and their network 
44
. 
The working definition of perceived symptom manageability addresses this aspect by incorporating the 
degree to which an individual perceives that they have symptom management strategies at their disposal and 
the skills to use them to live at ease with their symptoms. Perceived symptom manageability may be espe-
cially important for symptoms that often involve a person’s environment or threaten personal integrity. For 
instance, fatigue or vomiting 
45,46
 may impede social contacts or working capacity. Some patients manage 
well, some do not, often unrelated to the severity or frequency of symptoms. Also for skinny arms and legs, 
both symptoms attributable to HIV treatment, the individual perception of manageability is only partly re-
lated to severity or frequency. Dealing with these symptoms may be challenging because of the stigma at-
tached to HIV and the threat to individual integrity inherent in unwanted disclosure 
47,48
. Assessing the abil-
ity of a PLWH to manage these symptoms may elucidate symptom-related areas for intervention that com-
plement symptom alleviation as measured by severity or frequency.  
We claim that ‘manageability’ can be defined for symptoms, integrates the subjective evaluation of 
emotional and cognitive processes in the face of symptoms, as depicted by Spirig et al. 
8
 and Leventhal et 
al. 
7
 and that it can be a useful concept to identify symptoms needing management as perceived by 
PLWH. The use of the concept in questionnaires targeting different populations, as well as the different 
semantic usages identified in our database search, provide evidence for the flexibility of the concept and 
that its use with symptoms lies within the scope of the concept. Although the concept is not yet used with 
PLWH, there is some evidence that PLWH interpret some HIV symptoms as threats 
47,48
 or as difficult to 
deal with 
45,46
, which may impede symptom manageability. Therefore, we claim that the concept can also 
be used with PLWH to identify symptoms needing management and negotiate strategies, which increase 
their perceived ability to manage symptoms.  
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The importance of a supportive network is evident in the descriptions of manageability 
25-27
 and 
thus verifies the framework suggested by Spirig et al. 
8
. Healthcare providers, among others, represent an 
important source of information and support for PLWH 
49. Understanding the patient’s interpretation of a 
symptom by addressing its manageability in daily life—the aspect of dealing/living with symptoms of the 
working definition—may create an environment where health care providers and PLWH can establish a 
true collaboration. Addressing and discussing patient worries seemed to facilitate successfully dealing 
with a symptom, even if there were limited treatment options 
48,50
. Moreover, studies in HIV populations 
have shown that a positive appraisal of illness-related phenomena supports living successfully with this 
chronic condition 
51,52
. However, it is important to note that merely using ‘manageability’ will not make 
the difference and the interpretation of the concept by providers may still be different from its use by 
patients 
22,53
 and needs exploration. The manageability of treatable or untreatable and visible or invisible 
symptoms would be an interesting area for future research using the concept.  
Emerging evidence that the perception of control and the ability to deal with symptoms might be 
relevant to several outcome measures, e.g. the quality of life or adherence, points to the importance of our 
concept for future research and patient care. In previous studies of chronic illness management, perceived 
control moderated the improvement of self-efficacy 
54
, whereas a perceived lack of control was associated 
with decreased quality of life 
55
, self-care behaviour 
56
, medication adherence 
57
 and increased distress 
58
.  
CONCLUSION 
The concept synthesis procedure guided our process to explore the concept of ‘manageability’ and 
translate its generic use to a symptom-specific use. Our working definition of perceived symptom manage-
ability combines symptom control with 2 dimensions relating to the continuing challenge of living with 
HIV symptoms: (1) the availability of social resources and (2) the notion of successfully dealing with and, 
thus, integrating emotional and cognitive aspects. Integrating perceived manageability into symptom as-
sessment in addition to using objective measures focusing on physiological state represents, in our opinion, 
is an interesting approach for negotiating symptoms that need management in PLWH and identifying new, 
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patient-defined areas for intervention. While further research is needed, our working definition is a promis-
ing starting point in developing a measure that might help to improve the care of PLWH.  
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ABSTRACT 
Rationale: For people living with HIV, commonly used parameters for identifying symptoms 
needing attention cover symptom severity, frequency, and distress. These parameters, however, do not 
integrate the challenges of symptom management in daily living. This study posited that a broader per-
spective is needed to identify symptoms needing management. Therefore, we introduced the concept 
‘perceived symptom manageability’ and developed a working definition of this concept. 
Aims and objectives: The aim of the study was to verify the working definition and identify the 
components of the aforementioned concept as expressed by patients.  
Design and justification: A secondary analysis of interviews with 13 HIV long-term survivors us-
ing conventional content analysis was conducted. Employing a qualitative approach, we captured the 
lived experience of people with HIV by incorporating individual and dynamic facets of that experience.  
Ethical issues and approval: All participants provided written informed consent to primary and 
secondary uses of narratives and ethical committees approved the study from which data were taken. 
Confidentiality was guaranteed. 
Results: A symptom was perceived as manageable if it was reconcilable with professional, social, 
and personal activities. Contributory factors were keeping interference endurable, being embedded in an 
accessible supportive network of professionals and laypersons, and being placid in the view of HIV.  
Study limitations: The limitation was that our analysis was based on an already existing pool of 
interviews, which could not be expanded. 
Conclusions: With ‘perceived symptom manageability’, we present a novel approach for clinicians 
to identify symptoms needing awareness. Using an inductive approach, we gained detailed and specific 
information on patients’ lived experience, enabling patient-centred and individualized care. Asking pa-
tients about symptom manageability expands the currently employed parameters used to identify symp-
toms needing management and acknowledges the challenges of living with this chronic illness, notwith-
standing good medical treatment.   
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INTRODUCTION 
Despite tremendous advances in medication therapy, people living with human immunodeficiency 
virus (PLWH; HIV) can be confronted with numerous symptoms, from comorbidities, the illness itself, 
and treatment side effects 
1
. For PLWH, symptom management is a daily task, and the identification of 
symptoms needing management is an important issue in patient/provider encounters. However, parame-
ters commonly used to identify symptoms needing attention, that is, symptom severity/ intensity, frequen-
cy, and distress, provide a limited perspective on the daily challenges posed by symptoms. We presumed 
that to fully understand and identify the symptoms needing attention from the patients’ perspective, a 
more comprehensive approach is needed. Thus, we suggested the concept of ‘perceived symptom man-
ageability’.  
‘Perceived symptom manageability’ represents patients’ view on symptom management. To grasp 
patients’ perception of illness, a subjective illness theory such as the Common Sense Model (CSM) by 
Leventhal et al. 
2,3
 is a useful framework. The model’s adaptation for PLWH by Spirig et al., the Self-
regulatory HIV/AIDS Symptom Management Model (SSMM-HIV)
4
, is especially helpful.  
The SSMM-HIV, like the CSM, is a recursive model, meaning that the patient’s evaluation of the 
intervention outcome feeds back onto their interpretation of the targeted symptom. The model consists of 
various elements, namely illness representation (referring to identity, cause, timeline, control, 
consequences, and cure probability of an illness), symptom experience (comprising symptom severity, 
frequency, and distress), social support, symptom management activities, adherence, and influencing 
factors such as demographic and cultural influences, or sources of information. Successful symptom 
management might increase quality of life and influence clinical outcomes favourably. The CSM and the 
SSMM-HIV underscore the intrinsically individual interpretation of an illness and its symptoms and the 
recursive nature of the management process. As with the CSM, the SSMM-HIV is coherent within itself 
and consistent for individual patients 
4,5
. The ongoing and challenging work involved in integrating the 
known and new symptoms of a chronic illness into daily routine 
6
, coping with the dynamic nature of 
some symptoms 
7
, and the evaluation of successful symptom management is thus subject to individual 
interpretation and the interplay between the elements identified in the SSMM-HIV. Therefore, identifying 
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symptoms needing management requires a wider perspective than that of the parameters commonly used 
to identify symptoms needing attention, that is, symptom severity/ intensity, frequency, and distress.  
In an endeavour to establish ‘perceived symptom manageability’, our research team recently con-
ducted a literary-based synthesis of the concept 
8
 and presented the following working definition: “The 
extent of the perceived ability to bring social and personal resources into play to successfully deal 
with/control symptoms despite difficulties.” (authors, available online). In the current study, we sought to 
verify and further develop this working definition by inductively exploring components of the concept as 
identified by PLWH. We deemed the inductive approach as fitting our intention, because (a) we could 
only assume what might be important for PLWH and (b) existing evidence did not provide sufficient sup-
port for interpretation of the concept in its new area of use. We therefore analysed existing narrative in-
terviews with the goal of describing PLWH’s perception of living and dealing with their symptoms.  
METHODS 
Design. We based this exploratory, descriptive, and qualitative study on 13 existing open-ended in-
terviews that had been conducted in a study on medication and symptom management (authors, in press). 
To conduct this secondary analysis, we used a conventional content analysis approach 
9
. We deemed that 
the nature of the research question regarding patients’ descriptions of the important aspects of managing 
symptoms was appropriate for qualitative inquiry. Content analysis can be employed to structure a text 
along predefined categories or develop categories inductively 
9
. Using conventional content analysis in-
ductively, with emerging categories, we were able to capture the lived experience of PLWH by incorpo-
rating the individual and dynamic facets of that experience 
9,10
. The focus of the content analytical ap-
proach lies on the systematic analysis of symbols, which are the basis of meaning in any form of commu-
nication 
9
. Yet, the approach does not limit text exploration to obvious and visible content and allows the 
emergence of latent meaning. Consequently, a certain extent of interpretation cannot be avoided 
11
. To 
preclude unrestricted interpretation, we used a systematic and specific analytical process, following ex-
plicitly described rules 
9,12
.  
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Context, Setting, and Data. Approximately 70% of the PLWH living in Switzerland participate in 
the Swiss HIV Cohort Study, an ongoing multicentre research project established in 1988, taking place at 
seven outpatient clinics of Swiss hospitals (Zürich, Basel, Berne, Geneva, Lausanne, Lugano, and St. 
Gallen) (http://www.shcs.ch). In Switzerland, health insurance is compulsory for all persons living in the 
country. Most health expenses, including treatment and care costs within the SHCS, are covered by a 
basic insurance package and can be reimbursed. The interviews employed for this secondary analysis 
were conducted in 2005 in four sites of the Swiss HIV Cohort Study (Zurich, Berne, Basel, St. Gallen), 
within the scope of a larger mixed-methods study, which was concerned with symptom experience and 
management of PLWH, their close support persons, and health care providers and comprised quantitative 
descriptive/correlational and qualitative/hermeneutical components (authors, in press). For primary data 
collection, PLWH were contacted twice, first by physicians, and subsequently by study nurses, and asked 
if they would be willing to participate in the quantitative survey as well as in the qualitative enquiry. Of 
those who consented to both, interviewees were chosen purposely on the basis of gender, age, and trans-
mission group, as appropriate for the hermeneutical approach chosen for primary analysis. Primary data 
collection integrated the quantitative data of 268 PLWH cared for at the four aforementioned HIV outpa-
tient centres, and the qualitative data of 13 PLWH.  
Semi-structured interviews were conducted by three Master’s prepared nurses with extensive inter-
view training, under close supervision of an experienced qualitative researcher. Interviews were conduct-
ed either at the hospital in a separate room or at the PLWH’s home, as preferred by the participant. The 
interviews, all of which were between 45 and 75 minutes long, were audiotaped, transcribed verbatim, 
and stored as .rtf files. 
Ethical considerations. Patients providing written informed consent for the quantitative compo-
nent of the primary study were also asked to participate in the interviews of the qualitative component. 
Those who consented to the interviews were asked for permission to use their interviews for further anal-
ysis. All interviewees agreed to the further use of interview data. Local and regional ethical review boards 
of all participating hospitals approved the study protocol. 
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Sample description. Interview partners were diverse with regard to age (nine participants were be-
tween 40 and 50 years old, and four were younger than 40 years), origin (rural (6)/urban (7)), homo 
(6)/heterosexual (4)/no (3) partnership, and living situation (with children (2)/single or partnership with-
out children (11)). The group of PLWH consisted of eight men and five women. Four participants had a 
history of intravenous drug use. Interview data revealed that 7 of the 13 PLWH had been living with HIV 
for more than 10 years, and the narratives presented rich data regarding their experiences in managing 
symptoms. Compared to the 255 remaining PLWH in the primary sample from which these 13 PLWH 
were drawn, no major differences in age, CD4 cell count, HIV-1 RNA copies/mL, or median of prevalent 
symptoms were identified.  
Interviews. The patients were asked an opening question about their symptom experience in gen-
eral and how they manage. The interviewers were trained to elicit information on the following topics: 
symptom management, medication management, types of symptoms to be managed, collaboration with 
care providers, close support persons, and others in view of symptom and medication management and 
how PLWH would describe collaboration with these individuals.  
Data Analysis. For this secondary analysis, the transcribed content of the interviews was trans-
ferred to a Microsoft Excel (Microsoft, Inc., Redmond, WA, United States) file to facilitate the coding 
process. We analyzed data in accordance with the content analysis method described by Mayring 
9
 as 
follows: 
1. While reading the interview transcript, passages containing information on living with 
symptoms, management of symptoms, and symptom self-management strategies, as well 
as context and outcome, were identified, extracted from the transcripts, and paraphrased. 
More specifically, content not relating to the above topics was deleted and the content 
was abstracted by rephrasing the text on a non-personal level. Grammatical short forms of 
paraphrases were created. 
2. Aspects of symptom manageability emerging from the paraphrases were identified and par-
aphrases were reworded (generalized) on a shared level of abstraction, thus forming de-
scriptive codes. 
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3. Repetitive descriptive codes (generalizations) with equal content were merged. Merged codes 
were further condensed into larger categories defined by theoretical similarities among codes. In-
terviews were continuously cross-monitored to ensure consistency of codes and categories with 
the original text. 
4. Categories were used to identify shared themes (latent content) among the study participants; 
themes were compared and visualized in a preliminary diagram, which was submitted to rigorous 
examination by two qualitative researchers with expertise in content analysis and then to a peer re-
view by experts in qualitative methods other than content analysis, as well as two PLWH not partic-
ipating in the interviews who had acquired HIV before highly active antiretroviral therapy 
(HAART) was introduced. The feedback from these people was integrated in the description of the 
findings, and changes were crosschecked by in-depth comparison with the original interview texts 
until agreement among the researchers was achieved.  
The entire analysis process was closely supervised by two researchers experienced in the care of 
PLWH, as well as in content analysis. All interviews were conducted in German. The cultural and linguis-
tic adequacy of translated quotes was checked by a professional translator.  
RESULTS 
Overall, a symptom was perceived as manageable if it was reconcilable with professional, social, 
and personal activities. Contributory factors were keeping interference endurable, being embedded in an 
accessible supportive network of professionals and laypersons, and being placid in the view of HIV. 
Keeping interference endurable 
Familiarity with a symptom enabled PLWH to choose management strategies through which 
symptom interference with daily life could be kept at an endurable level. Knowing a symptom’s origin 
seemed of utmost importance, and a symptom with a non-identifiable cause could trigger a feeling of 
insecurity, as a woman with severe back pain of unknown origin stated:  
84 | CHAPTER 4 
 
However, it is very bad if one has something, like pain, and no one knows what to do or has an ex-
planation for it. This has been very bad indeed, and this has also been the only time that I have started 
studying medical books and checking the Internet a hundred times a day, just to see what can be done and 
what could be the cause. [E] 
In our sample of 13 PLWH, familiarity with a symptom was achieved by acquiring information and 
knowledge about the symptom’s origin, course, and predictability. Health care providers, books, and the 
Internet were mentioned as important sources of information.  
Apart from knowing the origin of a symptom, its predictability was an important aspect of manage-
ability. As one patient explained, learning about one’s bowel activity allowed anticipatory behaviour such 
as getting up early for proper toileting or using pads to prevent embarrassing situations with diarrhoea. 
[A, M] Unexpectedly occurring symptoms such as sudden vomiting remained overwhelming and cumber-
some, as the following statement by a woman illustrates. “Yes, there are things which are really frighten-
ing—for example, every time I am at a congress, I have massive problems at the buffet and often vomit 
without warning, suddenly, unpredictably.” [E]  
In cases of multiple symptoms, management strategies do not seem easily available, and keeping 
up a daily routine seems difficult and wearisome. The challenge in such cases is keeping several symp-
toms in balance, and ensuring their joint interference is acceptable, as the following quote by a woman, 
who works full-time in a team, illustrates:  
Keeping up performance if I feel blue is really exhausting and uses up all my energy. Tiredness, 
sleeping problems, and mood swings are very bothersome; this needs to change. If those sleeping prob-
lems could be reduced or resolved, and possibly the mood swings improved, then another equilibrium 
would develop, even if symptoms did not disappear entirely. [C]  
Knowing and using effective management strategies. The ability to maintain tolerability of a 
symptom’s interferences with workplace, individual, or social scopes of action contributed substantially 
to symptom manageability. One element was the knowledge and employment of effective management 
strategies. A middle-aged man, for instance, explained that a symptom for which cure or treatment was 
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readily available and easily applicable would not interfere with any of these areas, and management strat-
egies could easily be integrated into the daily routine. Two male participants pointed out, “Using a spe-
cial soap or cream for dry skin…this is easily integrated into everyday life, and no big thing, because it 
creates no limitations.” [D] Although the example describes total symptom control, PLWH did not pri-
marily expect symptoms to disappear entirely and limitations not exceeding a certain extent were accept-
ed. For instance, in case of hastened physical exhaustion, reducing workout time to ensure that one’s 
physical capacities were not overstretched was an accepted limitation. [N] The perceived physical, social, 
or mental limitations that substantially interfered with a person’s activities because of the severity or fre-
quency of a symptom, the unpredictable and sudden occurrence, and the uncontrollable effects of a symp-
tom, however, were perceived as unacceptable and not well manageable. Memory problems, which inter-
fered with individual plans, or sickness and migraine, which interfered seriously with work capacity, were 
two examples, illustrated by the following two quotes from a 43-year old woman and from a man work-
ing in a highly demanding position. 
When it all started—when I realized that something was wrong with me—I had memory problems 
and couldn’t learn anymore; this I found extremely difficult. This was frightening—I wanted to make up 
for the college diploma and go to university and then I couldn’t remember what I had read—one thing 
was, okay, I am too ill to study—the other thing was that I couldn’t use my brain anymore.[B] 
It happens that I cheerfully get up in the morning, go to work, and suddenly I feel sick and bad. 
This sickness might disappear after a while, but sometimes, a migraine develops, and I have great diffi-
culties in concentrating, which can be dangerous in my job. [N] 
Some participants pointed that visible symptoms were specifically difficult for them to manage be-
cause of the social and personal consequences, as one participant commented about fat redistribution: 
“Exactly—the fat redistribution is somehow closer, because it is something everybody immediately rec-
ognizes and associates with HIV, isn’t it? It always comes first; then, afterward, it defines the whole life.” 
[B] And as a mother of two children commented: “…Well, it has been very difficult for me, it is as simple 
as that. I had many problems with fat redistribution—this has been the worst thing for me and it is very 
distressing. (…) I think things are more difficult to handle if they are visible.” [H]  
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Supportive network 
Interviewees pointed toward the importance of cultivating and securing a functioning supportive 
structure, which included health care providers as well as laypersons. Providers were primarily responsi-
ble for health-related information and symptom alleviation, and laypersons mainly provided quick and 
non-bureaucratic instrumental support if needed and both were mentioned in the context of emotional 
support. Ideally, people in the supportive network were accessible in times of need and informed about 
HIV—they did not ask ‘unnecessary questions’ (one patient) and did not need many explanations in case 
of emergency. Appreciation for immediate access to health care providers in specialized facilities in case 
of an unknown symptom was emphasized by one man with the words: “It was very important for me and 
provided a sense of security, because I always knew I could go to the hospital—day and night.” [G]  
The following words of a young man might serve as an example for concrete support provided by 
laypersons: “On some days, I already have a stomach ache when I wake up—real aches—so badly that I 
can’t work. Then, to keep the farm running, my wife or my father need to step in.” [L] A woman in her late 
40s conveyed how important laypersons were in case of emergencies for her: “Then, if certain symptoms 
occur, it is very important that you can ask someone like neighbours to give you a ride to the hospital.” [E] 
Medical doctors were not only described as sources of information but also as important sources of 
emotional support by accepting a patient’s request for affirmation, as the following statement by a 40-
year old man illustrates: “Well, for me, it is very helpful (…) if the docs take it seriously, you know” [B] 
or “…If I would like to have, for instance, a lung screen, they [the doctors] are willing to refer me to 
specialists, if this is important for me” [H] and “It would be nice if the doctors accepted that although my 
lab parameters are excellent, there can still be problems with symptoms.” [N] The recommendations of a 
health care provider relating to one man’s lifestyle, however, were sensed as intrusive and unwelcome, 
and were described as follows: “Then the doctor said ‘you need to quit cigarettes’, ‘you need to lose 
weight’, and ‘actually, vegetarian food would be good for you’. This, I found, was too much—these are 
personal issues. I then asked to change doctors.” [E] 
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Placidity in the view of HIV 
Symptom manageability, to a certain extent, also seemed to be influenced by individual attitude 
toward the illness. When asked about symptom manageability, PLWH responded with a varying extent of 
urgency when explaining the importance of acquiring information, support, and clarity about the symp-
tom. Some participants, for instance, insisted on immediate support from their resources, whereas others 
displayed placidity handling symptoms. One or the other was expressed in all narratives, and some partic-
ipants stated that a change from the urgency to explain and control a symptom to a more placid approach 
was possible over time. One participant who had been HIV positive for 25 years and had taken medica-
tion since 1990 explained: 
By and by, I became expert in dealing with HIV—for example, I judged things differently than the 
doctors, which for them certain occurrences would be new and sometimes frightening, but are incidents 
which belong to my everyday life. Then, I sometimes ask the doctor to be patient and to wait and see. [D]  
Although the urgency might decrease over time, it remains part of the experience, as the following 
quote from an interview with a woman in her early 50s illustrates: 
The difference is, you know, that nowadays, slowly but steadily, it is recognized that a positive test 
result does not represent a death sentence anymore—also I know. But somewhere, deep inside, there is 
this feeling that I am living on a razor edge and that there will be the onset of the disease—there is just no 
guarantee that there will be NO onset. One little piece [of the illness] is not controllable—it might be very 
small, but it is there. It is there. [C] 
One of the two PLWH contacted for feedback on preliminary results had been living with HIV for 
more than 20 years and summarized the two faces of living with HIV: 
Well, now I am without fear or anxiety, even placid—for me, it has been the decision to trust in the 
medical system. I remember other times, when fear was my daily company. I still recognize this fear when I 
am talking with people who are newly diagnosed, who need explanations for everything. I can also imagine 
that fear and uncertainty would return if, for example, I learned that my medication would not work any-
more because of the development of resistances. [X]  
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DISCUSSION 
Summary of aim and concept components  
The current study was conducted to validate, expand, and refine the theoretically developed working 
definition of perceived symptom manageability by inductively exploring the components of the concept as 
identified by PLWH. Employing conventional content analysis, we identified three main components con-
tributing to the perceived manageability of a symptom, which, overall, was described as the ability to recon-
cile a symptom with everyday life. A symptom was perceived as manageable if PLWH were able to keep its 
interferences with daily activities at an acceptable level and if PLWH were embedded and secured in a sup-
portive network. Furthermore, we found that interviewees approached their health situation with an attitude 
between placidity and urgency, which was also reflected in PLWH’s approach to symptoms. 
Our components ‘keeping symptom interference with everyday living at an acceptable level’ and 
‘being embedded and secured in a supportive network’ confirm recently published findings from a quali-
tative study in women with chronic pain 
13
 contributing to well-being, which, eventually, may also be a 
result of good symptom manageability. Specific to our population was the dynamic nature and unpredict-
ability of some symptoms, demanding a high flexibility of the PLWH and the supportive network, which 
is similar to findings from other studies 
7,14
. Moreover, excluding the limitations and emotional conse-
quences linked to living with a chronic illness when identifying symptoms needing management only 
partly reflects these patients’ experiences, as has already been discussed in studies by other authors 15,16. 
Although symptom severity and frequency are important elements of manageability assessment in 
PLWH’s perception, exclusively concentrating on them represents a limited perspective on PLWHs’ lived 
experience. Fatigue, mood swings, cognitive impairment, unexpected occurring symptoms, and changes 
of appearance caused substantial limitations of a person’s scope of action and were especially burden-
some. Unfortunately, for these symptoms, only limited treatment options are available, and the elabora-
tion of individualized management strategies is especially important to enhance perceived symptom man-
ageability 
17
. Furthermore, because HIV stigmatization remains widespread 
18
, the potential for unwanted 
disclosure and the perceived reduction in a person’s worth because of the visible symptoms of their HIV 
are issues which still need to be addressed.  
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Receiving various types of support from a defined network of laypersons and professionals was the 
second component of ‘perceived symptom manageability’ identified in our analysis and was essential to 
PLWH perceiving symptoms as manageable. The kind of support received comprised affective, affirma-
tive, and instrumental elements, and concurred with social support as defined by Kahn and Antonucci 
19
(p.267). PLWH assigned health knowledge primarily to professional care persons and expected infor-
mation from them, whereas instrumental support was ascribed to laypersons. Affirmation, defined as sup-
port through agreement with what people do or say, and affect, comprising love, admiration, or respect 
19
, 
was received from both groups. Laypersons offered affirmation by knowing what was needed, accepting 
sudden needs, and not asking questions. The disappointment apparent in some PLWH’s accounts where 
affirmation was not received from providers if they, for instance, were perceived as not listening to 
PLWH, or not accepting the existence of a PLWH’s problem, points toward the significance of emotional 
support from health care providers.  
The third component of perceived symptom manageability refers to placidity in the view of living 
with HIV. Very similarly, the quest for harmony has been identified in patients living with other chronic 
illnesses 
20
. Despite constantly developing treatment options, the vulnerability because of the vagueness 
and, to a certain extent, uncertainty of the HIV illness trajectory 
21
, might not entirely be eradicated. Alt-
hough in the course of increasing experience with HIV, PLWH might gain confidence and the uncertainty 
of the HIV illness trajectory will be reduced 
21-23
, the perceived stability of the living situation seems frag-
ile and only relative.  
Adaptation of the working definition 
Our findings contribute to the refinement of the theoretically developed working definition in several 
ways. Our initial definition, “The extent of the perceived ability to bring social and personal resources into 
play to successfully deal with/control symptoms despite difficulties” reflects the individual skills necessary 
to manage symptoms and involves the social network as an important resource important for symptom man-
ageability. Although it integrates the notion of symptom control and mentions the difficulties with which 
people must cope it remains on an abstract level. Our analysis revealed that symptom control was not neces-
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sarily total medical control and symptom disappearance, but rather developing familiarity with the symptom 
by knowing its origin and engaging in behaviour that develops coherent management strategies. Manage-
ment success, then, was evaluated in terms of PLWH’s ability to keep the interference of a symptom with 
their scope of action in the social, professional, and personal realms at an acceptable level. The ability to 
bring social and personal resources into play can be differentiated as the necessity to secure a flexible and 
accessible supportive network, providing emotional and instrumental support and information, and the 
skilled development and employment of management strategies by the PLWH.  
On the basis of our findings, we therefore suggest adapting the theoretical working definition of 
perceived symptom manageability for long-term HIV survivors as follows: “Perceived symptom manage-
ability relates to the extent of the perceived ability to secure information, and emotional and instrumental 
support as well as to apply tailored symptom management strategies to keep a symptom’s interference 
with the social, professional, and personal realms at an acceptable level.” 
Strengths and limitations  
A major strength of our study relates to using an inductive approach to gain detailed and specific 
information, enabling truly patient-centred and individualized care. Acknowledging the facets of lived 
experience and integrating them into a theoretically deducted concept increases its credibility, signifi-
cance, and validity for the target patient population and health care providers. Moreover, by integrating 
patient perspectives, the boundaries of provider-defined parameters commonly used to identify symptoms 
needing management interventions might be traversed and enlarged. 
The limitations primarily referred to the fact that the analysis was based on an existing pool of interviews, 
which could not be expanded. However, we were able to verify the results with two PLWH who had not previ-
ously participated in the interviews. Nevertheless, more in-depth information is needed on all components, such 
as determination of the relative importance of each of the components within the HIV trajectory. 
Although interviewees are comparable regarding CD4 counts and RNA to the sample from which 
they were chosen, they represent only a specific group of PLWH; most participants have been living with 
the illness for many years, all were under close medical supervision employing the latest evidence on the 
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illness and medical treatment options and were in relatively stable health. The findings of qualitative 
analyses are always context-driven, so our findings might be different in people newly diagnosed with 
HIV, in an acute state of illness, or with poorer treatment, as might be the case for PLWH living in re-
source-poor settings. Therefore, although it uses an in-depth approach, our analysis is based on a small 
and specific sample of PLWH, providing only a first insight into the topic. 
CONCLUSION 
With ‘perceived symptom manageability’, we have presented a novel approach for clinicians to identi-
fy symptoms needing awareness. In drawing attention to patients’ lived experience and asking them about 
symptom manageability, we have expanded the currently employed parameters used to identify symptoms 
needing management and have acknowledged PLWH’s emotional burden of living with a chronic illness 
despite good medical treatment. Health care providers hold a special role—not only are they are a source of 
information, but the fact that they represent a valuable source of affirmation and, thus, emotional support is 
also equally important. Integrating the potential for emotional support into symptom management negotia-
tions might contribute to more mutual understanding and increased satisfaction with the encounter. 
Further research is needed to test the usefulness of the concept in daily practice and its relation to 
relevant outcomes. Moreover, to further verify the concept within the broader PLWH population, addi-
tional qualitative research is needed to provide information on such notions as the relative weight of con-
cept components across the entire illness trajectory. 
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ABSTRACT 
Background: Managing symptoms in daily life is a challenging problem for people living with 
HIV. As traditional parameters used to identify symptoms needing management do not integrate aspects 
of daily living with symptoms, we introduced ‘perceived symptom manageability’ to fill this gap.  
Aim: To quantitatively explore ‘perceived symptom manageability’ in a sample of 268 persons liv-
ing with HIV.  
Methods: Secondary analysis of existing cross-sectional data. Social support, gender, age, depres-
sive and anxiety symptoms were bivariately and multivariately analysed and related to symptom experi-
ence and manageability as measured by the HIV Symptom assessment scale and the HIV Symptom man-
ageability scale. 
Results: Least manageable symptoms were hair loss, vomiting and insomnia. Multivariately, age 
(Beta=-0.11; p=.024), symptom distress (Beta=-.62; P<.001) and total anxiety and depressive symptoms 
(Beta=-.18; p=.003) were statistically significant correlates of the concept.  
Conclusions: Although a promising concept to identify symptoms needing management, further 
research employing primary data is recommended.  
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INTRODUCTION  
Despite improvements in antiretroviral therapy and access to care in developed countries, persons liv-
ing with HIV (PLWH) may experience a host of disturbing symptoms 
1
 across their illness trajectory. As for 
other patients with chronic illnesses, managing symptoms and integrating them in daily living remains a 
major portion of illness management also for PLWH. Although a great share of the illness management is 
performed by patients outside the health care setting, health care providers represent important collaborators 
for PLWH in identifying and negotiating symptoms needing management, as well as initiating appropriate 
management strategies 
2
. It is widely accepted that an individual’s symptom experience, an amalgamation of 
emotional and cognitive components, should serve as the basis for determining symptom management 
needs. However, the traditional parameters representing symptom experience may not adequately identify 
symptoms needing management in persons living with a chronic illness. More specifically, symptom severi-
ty, frequency, and associated distress 
3-5
 do not take into account the context of living with symptoms and 
managing them in every-day life. Therefore, we propose that the introduction of a concept representing the 
patients’ perspective on symptoms needing management is timely and necessary.  
Based on the clinical observation that PLWH often use ‘not manageable’ when describing 
symptoms interfering with their lives and that these symptoms may or may not be severe, frequently 
occurring, or even distressing, we hypothesized that ‘perceived symptom manageability’ holds promise to 
expand the current focus on symptom experience assessment by providing a comprehensive 
understanding of symptom management as perceived by PLWH. In an endeavour to explore ‘perceived 
symptom manageability’, our research team chose to follow the procedural steps of concept synthesis 6, 
which encompasses the definition of a theoretical definition, its empirical verification and modification, 
and the development of defining attributes of the concept. Employing a mixed methods triangulation de-
sign 
7
 seemed appropriate to follow these steps. The development of a working definition of the concept 
8
, 
and the verification / modification using qualitative data 
9
 is described elsewhere. In the current study, our 
aim was to quantitatively explore and verify ‘perceived symptom manageability’ and position the concept 
within a theoretical framework. 
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Influencing factors available from the data set: 
depressive and anxiety symptomatology, age, 
gender, stable partnership, educational degree
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BACKGROUND 
The Self-regulatory HIV/AIDS Symptom Management Model (SSMM-HIV) 
The Self-regulatory HIV/AIDS Symptom Management Model (SSMM-HIV) was presented in 2005 
by Spirig et al. 
5
 and represents the conceptual framework for our exploration. According to this model, 
Symptom management in PLWH comprises a system of distinct and intertwined personal, symptom-
related, social, contextual, and behavioral factors, as shown in figure 1 and acknowledges the profoundly 
individual nature of perception. We consider perceived symptom manageability to represent the patients’ 
view on the symptom management concept, and integrate the elements outlined by Spirig et al. in their 
conceptualization of symptom management in PLWH.  
Figure 1. Model (Spirig et al, 2005) adapted to our analysis of proposed parameters contributing to symptom 
manageability 
 
 
 
 
 
 
Perceived symptom manageability 
Based on findings of the first procedural steps of concept synthesis, i.e., development of a theoreti-
cal definition and its first empirical verification, 
8,9, we assume that ‘perceived symptom manageability’ 
embodies a different and more comprehensive view on symptoms needing management than traditionally 
used parameters by incorporating the patients’ perspectives on a daily living with symptoms. Further-
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more, we assumed that the model presented above represents this comprehensiveness in a sufficiently apt 
way to serve as the basis to explore our concept. Thus, we hypothesized that the elements representing 
symptom management in the model are also represented in ‘perceived symptom manageability’. In order 
to verify ‘perceived symptom manageability’ quantitatively, we, therefore, explored the concept within 
the context of variables presented by the model.  
Aims of the study 
The aims of the study were to relate perceived symptom manageability to traditionally used symptom 
experience parameters, and to bivariately and multivariately explore correlates of ‘perceived symptom man-
ageability’ employing parameters of symptom management designated in the presented model.  
METHODS 
Study design. The current study is a secondary analysis of cross-sectional data collected for a 
mixed-method project investigating symptom experience in PLWH 
10
.  
Sample and setting. In the parent study, a convenience sample was used. Patients were recruited be-
tween June 2004 and November 2005 at the four outpatient clinics in the German-speaking part of Switzer-
land (Basel, Berne, Zurich and St Gall) that participate in the Swiss HIV Cohort Study (SHCS). The SHCS 
is a large prospective cohort study with continuing enrollment of HIV-infected individuals aged 16 years or 
older. Patients were eligible to participate in the parent study if they were HIV-infected and on antiretroviral 
therapy (ART), over 18 years of age, and German speaking. Local and community ethical committee ap-
provals were obtained for each of the study locations. Participants completed a survey packet and were 
asked to return the questionnaires within two weeks in pre-addressed and pre-stamped envelopes. To assist 
participants, the research team provided a hotline during office hours. If the questionnaires were not re-
turned in a timely manner, participants were reminded twice by a research assistant or by a study nurse. The 
first reminder occurred after 2-3 weeks, the second after 4-6 weeks. Research assistants checked survey 
forms for missing data upon receipt. If there were missing or equivocal values, participants were contacted 
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by telephone by either a research assistant or the study nurse for clarification. For this study, participants 
were excluded from the analysis if they did not report at least one symptom.   
Variables and measurements. Symptom experience (severity, frequency, distress) and managea-
bility ratings, socio-demographic and clinical variables, anxiety and depressive symptomatology, and 
social support were abstracted from the primary database and were measured in the following way.  
The symptom experience for 82 HIV-specific symptoms was measured by the HIV Symptom as-
sessment scale (HIV-SEAS) 
11
, which combined the symptom list from the ‘Symptom Check-List for 
HIV (SSC-HIVrev)’ 12 with the scaling of experience-related characteristics used in the ‘Memorial 
Symptom Assessment Scale (MSAS)’4. These instruments are often used and widely validated with 
PLWH. The symptom list was tested for comprehensibility and the adequacy of the symptoms by 
asking PLWH and HIV-specialized health-care providers and was adapted as described elsewhere 
11
. 
Validity evidence based on test content, scaling dimensions, and response process  were established for 
the combined questionnaire 
11,13
.  
The perceived ability to manage specific symptoms was assessed by The Symptom Manageability 
Scale (HIV-SMS). The question ‘how manageable was this symptom for you?’ was integrated in the HIV-
SEAS as the last question asked for each reported symptom and was answered using a 6-point Likert-type 
scale answering options (1 = very poorly to 6 = very well).  
Depressive and anxiety symptoms were measured by the German version of the Hospital Anxiety 
and Depression Scale (HADS) 
14-16
. The HADS was designed for use in non-psychiatric clinical settings 
and assesses anxiety and depression symptomatology. In the current study, for both subscales, scores ≥8 
indicated significant symptomatology.  
Emotional and instrumental support provided by the social network was measured using the Nor-
beck’s Social Support Questionnaire (NSSQ)17. The 9-item questionnaire measures three major components 
of social support – functional aspects, network and loss. For the purpose of this study, only subscale scores 
for functional aspects (affirmative, affective, and instrumental support) were used. Subscores are calculated 
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on the basis of a list of network members, initially provided by the participants. Six questions, two for each 
subscale, are rated using a 5 point rating scale (0=not at all to 4=very much). Subscale scores are calculated 
by summing up ratings of network members on the subscale questions. The scale has been translated into 
German by our team following the adapted Brislin protocol including forward- and backward translation 
and content validation by experts. Furthermore, the 3-dimensional structure suggested by Gigliotti et al. 
(affirmation, affect, and aid) has been confirmed and will be utilized in this study 
18
. 
Data Analysis. Data analysis was performed in three steps. First, descriptive statistics were gener-
ated for demographic, behavioral, psychosocial variables as well as the average perceived symptom man-
ageability across perceived symptoms and the prevalence of symptoms across the study sample. Total 
number of symptoms perceived by each participant was also calculated. Symptoms experienced by fewer 
than 10% of the participants and gender-specific symptoms were excluded from the analysis. 
Second, we explored the associations between overall symptom severity, frequency or distress and 
manageability at the symptom level. At the symptom level, the respective ratings of each symptom were 
averaged across all participants who reported experiencing the symptom. At the patient level, we 
averaged the ratings across all symptoms reported by each patient. Nonparametric and parametric 
methods were used as appropriate, depending on variable measurement level and data distribution.  
In a third step, bivariate and multivariate analysis was performed using average perceived symptom 
manageability as the outcome variable. Correlates potentially influencing the perception of symptom 
manageability (influencing factors from the Spirig model)
5
, were gender, age, stable partnership, highest 
educational degree, number of symptoms, depressive and anxiety symptoms, as well as symptom experi-
ence and social support. Using average manageability ratings at the patient level, bivariate correlations 
were conducted to examine the relationships between symptom manageability and psychosocial and de-
mographic variables. (i.e., Spearman correlation for non-normally distributed continuous data and ordinal 
data, point-biserial correlations between continuous and dichotomous variables and Pearson correlation 
for normally distributed, continuous data).  
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To explore the correlation of manageability with influencing factors on a multivariate level, averaged 
manageability ratings on the patient level were used as response variable and all influencing factors 
identified from the model were used as potential predictors. All variables were entered in an initial model. 
Then, as indicated by collinearity statistics, variables were removed one by one or collapsed as appropriate. 
All statistical analyses were performed using SPSS (Version 20, IBM SSPS Inc., Chicago, IL, 
USA). For each test, the level of significance was set at alpha=0.05. 
RESULTS  
Seven hundred forty-four patients on ART, participating in the SHCS, and >18 years old were invited 
to participate in the primary study. Among those who declined to receive study information (274), the main 
reason was a lack of time. Of the 382 PLWH who were eligible and agreed to participate, 107 did not return 
the questionnaires and were classified as non-responders, two participants withdrew their previously signed 
informed consent, and one participant was excluded from analysis due to 60% missing data, resulting in a 
final sample of 272 participants (36.6% of invited patients and 71.2% of participants who signed the in-
formed consent). One hundred fifty-five (n=155, 57%) patients were contacted to obtain missing data or to 
clarify responses (n=20), resulting in a reduction of missing data on symptom experience to less than 1%. 
For our analysis, 3 participants who did not report any of the 82 symptoms and one participant who did not 
provide information on manageability were excluded, yielding a total of N=268 PLWH.  
The sample consisted largely of white Swiss middle-aged males with basic schooling (i.e., 9 years of 
mandatory school and, generally, 3 years of profession-specific apprenticeship) (see Table 1). One third of 
participants had at least one AIDS-defining medical condition but few had viral loads of more than 400 HIV-
1 RNA copies per ml. The most probable mode of viral transmission was men having sex with men.  
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Table 1. Overall sample characteristics and psychosocial parameters of PLWH 
Variable Sample 
Total – n 268 
Male gender - %     78.3 
Age – median (IQR)                       44 (39 - 51) 
Swiss nationality - % 81.3 
White ethnicity - % 95.6 
AIDS - % 32.7 
CD 4 cell count (mmol/L) - median (IQR) 420 (295 - 589) 
HIV-1 RNA (copies/ml)  - % 
     <50  
       50 – 399  
     ≥400  
 
79.4 
9.6 
9.6 
Depressive symptoms 
b
 – no symptoms- % 79.1 
Anxiety 
b
 - no symptoms - % 69.4 
Social support (N=255)  
Affirmation
 c
 – median (IQR) 61 (35-90) 
Affect
 c
 – median (IQR)  58 (32-88) 
Aid
 c
 – median (IQR) 48 (29-70) 
IQR = interquartile range  
a  MSM: males having sex with males; MSF/FSM: males / females having sex with females/males 
 b measured by the Hospital Anxiety and Depression Scale (HADS) (score min-score max both scales 0-21;  
 0-7 = no symptoms, 8-10 = mild symptoms, 11-14 = moderate symptoms, 15-21 = severe symptoms) 
c measured by the Norbeck Social Support Questionnaire (NSSQ), affirmation / affect / aid subscale 
Twenty-one percent (21%) of our study participants had mild to severe depressive symptomatology 
and 31% had significant anxiety symptomatology. The median number of symptoms experienced by par-
ticipants during the past week was 16.5 (IQR: 9-25.75, range: 1-46). One patient reported having 46 
symptoms during the prior week.  
After excluding the 9 gender-specific symptoms, the prevalence of symptoms across participants 
ranged from 61.8% (n=168) for fear/worries to 1.1% (n=3) for nipple discharge. Twelve symptoms re-
ported by fewer than 10% of participants were excluded.  
10 most prevalent, severe, frequently occurring, distressing, and least manageable symptoms are 
summarized in table 2. Within symptoms, manageability scores were strongly and negatively correlated 
with distress scores (Spearman’s rho = -.753) and were nearly uncorrelated with symptom severity and 
frequency ratings (n. s.).  
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Table 2. 10 most prevalent, severe, frequently occurring, distressing, and least manageable symptoms 
Most Prevalent (%) Most Severe Most Frequent Most Distressing Least Manageable 
Fear / worries (61.8%) Sensitivity to insect bites Dry skin Headaches Hair loss 
Fatigue (53.3%) Insomnia/can’t sleep Thirst Caries/brittle teeth Vomiting 
Dry skin (52.2%) Vivid dreams Insomnia/can't sleep Insomnia/can’t sleep Insomnia/can’t sleep 
Weakness (50%) 
 
Fatigue Gas/bloating 
 
Heartburn Weight gain in stomach 
area 
Diarrhea (47%) 
 
Thirst Vivid dreams Increased sensitivity  
to insect bites 
Decreased ability to 
withstand psycho-
logical strain 
Depressed mood (46%) Lack of appetite Lack of appetite  Fatigue Anxiousness 
Gas/bloating (45%) Diarrhea Fatigue Anxiousness Skinny arms and legs 
Vivid dreams (44%) Constipation Dry mouth Vomiting Depressed mood 
Difficulty concentrating 
(43%) 
Increased appetite Fear/worries Fear/worries Fatigue 
Insomnia/can’t sleep 
(42%) 
Numbness/tingling in 
legs, feet and toes 
Diarrhea Nausea Caries/brittle teeth 
Bivariately, anxiety (Spearman’s rho =-.389) and depressive symptomatology (Spearman’s  
rho =-.287) and total number of perceived symptoms (Spearman’s rho =-.367) correlated with symptom 
manageability (p<.001). None of the social support dimensions (aid, affect, affirmation), nor any of the 
demographic (age, gender) or psychosocial (stable partnership, educational degree) was significantly 
related to symptom manageability.  
Collinearity diagnosis prompted us to collapse the anxiety and depressive symptomatology 
subscale scores into a HADS total score and aid, affirmation and affect into a ‘total functional support’ 
score. Multivariately, we found that age, gender, depression/anxiety symptomatology and symptom 
distress were significant correlates of symptom manageability (see table 3).                    
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Table 3. Multiple regression analysis for mean symptom manageability on patient level 
 
 
 
 
 
 
DISCUSSION 
We conducted a secondary analysis of data from PLWH collected in four Swiss-German centers of 
the Swiss HIV Cohort Study in 2004/2005 with the goal to expand the findings from a theoretical definition 
and its qualitative verification recently conducted by our team and to further verify the theoretically devel-
oped concept definition. Moreover, to our knowledge, this is the first quantitative study in this population 
exploring perceived symptom manageability in the wider context of a theoretical model and compare tradi-
tionally employed parameters to identify symptoms needing management with symptom manageability.  
The comparison of most distressing, severe and prevalent symptoms with the least manageable 
symptoms revealed that these dimensions seem to capture different aspects of a symptom. For instance, 
insomnia, fatigue and depressed mood, among the ten most prevalent, and vomiting, anxious, and fatigue, 
among the most distressing symptoms, were also found among the 10 least manageable symptoms. Physi-
cal changes, however, such as skinny arms and legs and weight gain in stomach area, did not fall high into 
the other dimensions and were found only among the least manageable symptoms and known to cause sub-
stantial distress 
19
. Because stigmatization due to HIV is still widespread 
7
, the potential for unwanted dis-
closure in case of visible symptoms is an issue which needs to be addressed. Although these symptoms are 
Model     
95.0% confidence  
interval for B 
 B (SE) Beta T p lower upper 
(constant) 6.063 (.276)  21.960 .000 5.519 6.607 
Age -.008 (.004)* -.109 -2.271 .024 -.016 -.001 
Stable partnership .020 (.051) .019 .401 .689 -.079 .120 
Gender .159 (.094) .082 1.688 .093 -.027 .345 
Symptom distress -.753 (.070) -.624 -10.789 .000 -.890 -.616 
Highest completed  
educational degree 
-.042 (.029) -.071 -1.442 .151 -.099 .015 
HADS total score -.020 (.007) -.182 -3.000 .003 -.033 -.007 
Total functional  
support score 
.000 (.000) .057 1.133 .258 .000 .001 
Number of reported  
symptoms 
.000 (.004) .006 .110 .912 -.008 .009 
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difficult to control from a medical perspective, supporting patients to gain a sense of symptom manageabil-
ity is of utmost importance to enhance overall well-being 
20
. Thus traditionally used parameters, indeed, 
may only elucidate a limited segment of symptoms needing management and miss symptoms with wider-
ranging impacts 
21
.  
Results of the multivariate analysis showed that our findings partially confirm the model underlying the 
analysis. Of the influencing factors analyzed, the correlation with symptom manageability could be substantiated 
for age, depressive and anxiety symptomatology, and symptom-associated distress; the latter two being well-
known correlates of HIV 
22,23
. As people continue to age with HIV, they are also confronted with comorbidities 
due to living longer 
24
, and managing symptoms may be more difficult, as suggested by our result.  
Given evidence 
25,26
 and the findings of our qualitative analysis that social support is a core variable in 
managing HIV, it was surprising this study did not find a relationship between social support and symptom 
manageability was surprising. One explanation could be a measurement issue. First, in the primary study the 
NSSQ questionnaire was utilized to measure social support in relation to overall illness management, not 
symptom management. Although symptom management is an integral part of illness management, the score 
may only partly reflect the role that a social network plays relative to symptom management. Second, the 
NSSQ targets dimensions of social support across the entire network. Specific types of support assigned to 
specific groups within a person’s supportive network as outlined in our qualitative exploration (i.e., instru-
mental support (aid) and affect to lay persons, affirmation to lay persons and health care providers) were 
omitted in this quantitative exploration. Moreover, the provision of information, which was also perceived 
as support and asked from health care professionals, was not included in any of the questions in the NSSQ. 
Therefore, the questionnaire may be too general and blur these specific types of support. A more differenti-
ated analysis of types of support by laypersons and professionals on the network list in the questionnaire 
might provide different results. Third, the sample we analyzed in the qualitative exploration might have 
been very specific, and the results, as always in qualitative analyses of this type, are context-driven and do 
not necessarily apply to the entire sample used in the quantitative analysis.  
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The high correlation between symptom distress and manageability was consistent across all anal-
yses, and remains a matter of further research. Clinically, questioning patients about distressing symp-
toms may be as suitable to identify symptoms needing management as asking patients about symptom 
manageability. No matter which parameter is used, the individual interpretation of the situation warrants 
further exploration and negotiation between PLWH and provider.  
Limitations of the study 
Comparing descriptive parameters displayed in table I might point towards a possible sampling bias 
due to the inclusion criteria, which stipulated the ability to read or speak German. Persons with good 
knowledge of the German language tend to have been born in a German speaking country or have been living 
in Switzerland for many years, tend to be integrated into the working process, and generally understand and 
follow instructions well. Therefore, neither the limited racial / ethnic diversity, nor good disease control is 
unexpected. The differences found preclude generalization of our results to the entire cohort. 
Our analysis was based on an existing data set and the assumption that perceived manageability 
represents a patient’s view of symptom management as conceptualized in a model. The qualitative analy-
sis, however, elicited factors contributing to perceived manageability, which could not be quantitatively 
explored due to the limitations of data available for inclusion in the current study. Moreover, qualitative 
findings are always context-driven; therefore, findings from a small sample of PLWH who have been 
living with HIV for many years may not be transferrable to a bigger sample of PLWH with different or 
shorter experiences with their condition.  
Implications for further research 
In order to better understand the patients’ concerns in view of symptoms needing management, an 
effort should be made to further develop a measure based on qualitative findings from a primary investi-
gation targeting symptom manageability. Moreover, in order to verify the value of the concept, the con-
cordance and differences between symptom-associated distress or bother and manageability should be 
further investigated. The relative importance of the dimensions identified in the qualitative analysis may 
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be temporal in nature, and the sensitivity of aspects of perceived symptom manageability to changing 
symptom profiles should be examined prospectively in future studies. 
CONCLUSION 
Although our findings reveal that the concept ‘perceived symptom manageability’ holds promise as 
a valuable alternative to commonly used parameters to identify symptoms needing management, evidence 
is far from conclusive. Moreover, due to the similarity of symptom distress and our concept, it is likely 
that they capture similar aspects. Given the evidence that manageability decreases with an increasing 
number of symptoms and the finding that most severe or prevalent symptoms are not necessarily the least 
manageable, symptom lists based on the most prevalent or most severe symptoms might not reflect a 
PLWH’s reality symptomwise, and might not capture less prevalent / severe symptoms related to low 
manageability in every-day life.  
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SYNTHESIS: INTEGRATION OF FINDINGS  
We proposed that the parameters traditionally used to identify symptoms that need management do 
not sufficiently embody PLWHs’ concerns regarding living with this chronic condition, which may result 
in under-recognition of bothersome symptoms. We therefore introduced "perceived symptom managea-
bility" as a concept, which we suggest incorporating the patients’ perspective on daily living with symp-
toms and that could be useful for clinical use to identify symptoms that need management. Moreover, 
using this concept may provide common ground for providers and patients to negotiate symptoms that 
need management and apt management strategies.  
Before the concept can be recommended for use in clinical practice, however, our assumptions 
must be verified. Since the concept has not yet been used in relation to symptoms, a concept synthesis 
1
 
seemed appropriate and allowed us to explore the suitability of the concept for our purpose, to transfer the 
concept from its current use to the new use and specify its use with symptoms, and to verify our assump-
tion that the concept can be used to identify symptoms that need management. Following the procedural 
steps of concept synthesis proposed by Walker and Avant 
1
, a mixed methods design seemed appropriate. 
More specifically, we first developed a working definition of the concept by integrating as many uses of 
the concept as possible based on an open search of the Internet employing various data sources (Chapter 
3). Second, we analyzed qualitative interviews (Chapter 4) using conventional content analysis to explore 
shared themes relating to the concept among a sample of 13 PLWH (Chapter 4), and third, we conducted 
an analysis of quantitative survey data to explore the conceptual context of perceived symptom managea-
bility (Chapter 5). As the overarching study of our project (SOLEXA) provided a rich database of qualita-
tive and quantitative data matching our topic, we decided to take advantage of existing data. Two of our 
three analyses drew from this data pool, and one analysis was based on additionally collected data. In 
mixed methods research, one of the most important steps is the combination of data, which eventually is 
the heart of the added value by this method. This step, however, should not be left to intuition. Although 
the concept synthesis procedure provides an overarching structure to combine data, the data combination 
process is not explicitly described in the literature; we therefore employed sources from mixed methods 
research to inform our integration steps. Data can be combined at various stages of the research process 
2
. 
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As our data were generated using different methods and were independently analyzed, the recommenda-
tion is that the integration takes place in the interpretation phase 
3
. This corresponds with our methodolog-
ical approach, in which findings from each source and method are not used in a competitive but rather in 
a complementary manner and contribute to a more comprehensive picture of the concept than each per-
spective alone would have allowed, thus serving an overarching aim and resulting in an integrative de-
scription of results. Within the concept synthesis steps 
1
, our data combination pursued three goals (see 
Diagram 1): to verify and modify the working definition resulting from step 1 of the concept synthesis 
procedure; to develop constituents of the concept; and to create exemplary cases of symptoms. Verifica-
tion and modification occurred at two points: first, at the integration of qualitative findings into the work-
ing definition and thus ensuring the integration of the patient perspective; and, second, at the incorpora-
tion of quantitative findings into the modified definition. The identification of constituents took the form 
of a further integrative step, providing a comprehensive view on components embraced by the concept 
(global assessment, Table 3). In a fourth step, quantitative and qualitative appraisals of symptom manage-
ability were combined and both convergent and divergent assessments of symptoms were used to create 
model cases and a borderline case. To enable maximum transparency in terms of the combination of find-
ings from different data sources or methods, Farmer et al. 
4
 recommend a triangulation protocol contain-
ing a set of six distinct steps, which highlight the steps taken at the integration phase of a project 
3,4
. Alt-
hough presented for qualitative data, the steps briefly described in the next paragraph also apply to inte-
grating findings from different methods, and were guiding our integration process.  
In a first step, findings from the different sources that address the research question are coded and 
categorized according to meaningful topics in view of the research question in a way that enables compar-
ison (sorting).  
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The second step refers to the identification of themes from each data source of method, and con-
vergence in view of the research question. Sorting and coding of data relating to our concept was integra-
tive to the development of the working definition and the qualitative verification. Coding and sorting 
using quantitative data was inherent to the method; the choice of data relating to the concept was based on 
the conceptual framework by Spirig et al. 
5
, which provided a comprehensive description of symptom 
management in HIV. This framework was also used to guide the sorting procedure for the overall integra-
tion of findings resulting in the global assessment of findings, described in further detail below and repre-
senting the core of this chapter. The "convergence coding scheme" provides an apt structure for assessing 
agreement (agreement between findings), partial agreement, silence (only one method provides themes), 
and dissonance (contradicting results) between data sources in view of the research question.  
The third step focuses on the global assessment of the overall convergence of the findings based on 
the convergence coding scheme. In our study, constituents were thematically grouped along concept ante-
cedents, defining attributes, and consequences derived from Spirig et al.’s framework, and the global 
assessment of overall findings comprised the overarching description of concept constituents.  
The fourth step that the authors recommend is completeness assessment. This refers to the com-
pleteness of the different sources in terms of the topic of interest and the completeness of the entire set of 
findings. During this process, for instance, differences in scope and/or coverage are identified. Researcher 
comparison (step 5) and feedback (step 6) denote the reflection and review of integrated findings by fel-
low researchers and stakeholders. Researcher comparison was provided by co-authors contributing to the 
analytical steps; and feedback was provided by all co-authors of the particular articles presented in chap-
ters three, four, and five.  
Developing and following a triangulation protocol, therefore, guides the integration process by de-
scribing the different steps taken, and the convergence coding matrix represents a key element in the trian-
gulation protocol by summarizing core findings from the analyses in a matrix structure and enabling a com-
prehensive picture and analysis of data from different sources. Our integration process was determined by 
the procedural steps of concept synthesis as the overarching methodology (Walker and Avant) 
1
, as follows.  
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First, we searched different sources to identify as many uses of the concept as possible. Second, us-
es were sorted, clustered, and overarching themes identified, which were condensed to a working defini-
tion (Chapter 3). Empirical verification and modification of the concept is the next step. To integrate the 
concerned persons’ lived experience, we conducted a content analysis of semi-structured interviews and 
refined the definition according to the emerging themes, resulting in a first empirically supported defini-
tion of the concept. For this developmental step, findings of the two analyses were integrated following 
the triangulation protocol represented in table 1. To further verify the concept and to determine its relation 
to existing theory and related concepts, we conducted bivariate and multivariate analyses (Chapter 5) of 
survey data generated on the basis of a conceptual framework on symptom management 
5
, which inte-
grates various influencing factors and correlates of perceived symptom manageability. The framework, 
therefore, offered an apt basis for coding findings as antecedents, attributes, and consequences of the con-
cept (see table 3).  
In a final step, convergence coding matrices for antecedents, attributes, and consequences of the 
concept are created (see tables 3.1-3.3). The following diagram and tables highlight the process how we 
combined findings from the three analyses in several distinct steps and developed main findings as dis-
cussed below. 
 
 
  
 
 Diagram 1. The combined integration and research process 
  
  
Triangulation Protocols 
Table 1. Triangulation protocol of qualitative concept verification and modification  
Integration 1: Refining the working 
definition by integrating qualitative 
findings 
Activity  Result  
Summary of as many uses of the  
concept as possible 
 Working definition:  Perceived symptom manageability 
denotes "the extent of the perceived ability to bring 
social and personal resources into play to successfully 
deal with/control symptoms, despite difficulties" 
Step 1: Sorting  Key themes that emerged from the qualitative analysis and those emerging 
from the first concept synthesis steps were listed.  
 
Step 2: Convergence coding Because qualitative analysis was used to fill the theoretically developed 
definition with meaning, inductively developed themes (for details, please 
refer to Chapter 4) were used to complement and refine the formerly creat-
ed working definition of the concept in an explanatory manner.  
 
Step 3: Convergence assessment Dealing with/controlling symptom denotes rather achieving familiarity 
with the symptom by knowing its origin and engaging coherent manage-
ment strategies than total medical control and symptom disappearance  
Success was evaluated in terms of PLWH’s ability to keep the interference 
of a symptom with the scope of action in the social, professional, and per-
sonal realms at an acceptable level.  
The ability to bring social and personal resources into play can be differ-
entiated as the necessity to secure a flexible and accessible supportive 
network, providing emotional and instrumental support and information, 
and the skilled development and employment of management strategies by 
the PLWH.
6
  
The working definition was adapted and a preliminary definition of the 
concept was created. 
Refined definition: “Perceived symptom manageability 
relates to the extent of the perceived ability to secure 
information, and emotional and instrumental support as 
well as to apply tailored symptom management strate-
gies to keep a symptom’s interference with the social, 
professional, and personal realms at an acceptable lev-
el.” 6 
Step 4: Completeness assessment In view of qualitative data and data from Internet sources  
Step 5: Researcher comparison and 
feedback 
The adapted definition has been critically reflected and approved by all co-
authors 
 
  
  
Table 2. Triangulation protocol describing the development of concept constituents using findings from qualitative and quantitative analyses 
Integration 2:  
Verification of the theoretical definition  
 
Step 1: Sorting  Components of the theoretical definition and results from the qualitative and the quantitative analyses were 
coded as "antecedents" (referring to elements that affect perceived symptom manageability); "defining attrib-
utes" referring to factors common to all integrated uses of a concept.  
"Consequences" refer to elements potentially affected by the concept.  
Antecedents and consequences were defined based on the SSMM-HIV 
5
. 
Step 2: Convergence coding Convergence coding matrices were used 
3,4
  
-  To compare and reflect findings from the quantitative and the qualitative analysis see table 3 and explore 
whether findings from the quantitative exploration confirm the theoretical definition of the concept  
-  To analyze the convergence of quantitative and qualitative findings relating to the concept constituents 
antecedents, defining attributes, and consequences (tables 3.1-3.3)  
-  To construct model cases by combined analysis of symptoms mentioned in qualitative interviews and were 
rated in the quantitative survey, as well as by the differentiated listing of symptom-related antecedents and 
consequences of manageability (table 4) 
Step 3: Convergence assessment Convergence codings were applied in terms of agreement, partial agreement, silence, and dissonance in view 
of concept antecedents, defining attributes, and consequences  
To provide a comprehensive understanding of integrated elements, the structure of concept analysis was em-
ployed (see below, tables 3, 3.1-3.3) 
Step 4: Completeness assessment In terms of data from quantitative survey and global assessment  
Step 5: Researcher comparison and feedback The representation and findings were reflected and approved by the PhD mentor (RS) 
 
  
  
Convergence Coding Matrices and Global Assessment 
Table 3. Global assessment: Convergence coding matrix, integrating findings on the research questions 
1
 as conceptualized in the SSMM-HIV 
5
: influencing factors; illness representation; symptom-related; social support; bold: additional components
Study Data used Identified antecedents
1
  Identified defining attributes Identified consequences
1
  
Concept synthesis Definition: “Perceived symptom 
manageability relates to the ex-
tent of the perceived ability to 
secure information, and emotion-
al and instrumental support as 
well as to apply tailored symptom 
management strategies to keep a 
symptom’s interference with the 
social, professional, and personal 
realms at an acceptable level.” 
A symptom’s interference with social, 
professional, personal realms 
Secure information, emotional and 
instrumental support as well as to 
apply tailored symptom management 
strategies 
The perceived ability to keep interfer-
ence at an acceptable level  
 
Qualitative  
exploration 
Shared themes contributing to 
perceived symptom manageability 
across interviewees (nr of persons 
who mentioned topic, N=13) 
Available symptom self-management 
strategies (13) 
Targeting symptoms (13) Interference with every-day life is tol-
erable in terms of (13) 
 Lifestyle (7) 
 Disclosure (7) 
 Role performance (5) 
  Symptom-related: severity, frequency (10), 
only implicitly 
Symptom predictability (4) 
Symptom visibility (3) 
Resource utilization: symptom con-
trol: treatment (13) 
Self-management strategies (12) 
 
  Accessible and available information (10) Resource utilization: information (10)  
  Accessible and available supportive net-
work (12) 
Resource utilization: aid, affirmation, 
affect (9) 
 
  Illness uncertainty (12)  Individually perceived ability to keep 
interference tolerable (13)  
Quantitative  
exploration 
Variables statistically significant-
ly associated with "symptom 
manageability" 
Symptom – related: symptom distress  
Personal:  
Depressive and anxiety symptomatology 
(HADS) 
age 
Focus on perceived symptoms Degree of manageability of perceived 
symptoms 
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The above components of the convergence coding matrix are transferred to three separate matrices illus-
trating concept constituents, thus enabling a slightly different picture of integrated findings. Agreement, 
partial agreement, silence, and dissonance in view of the research question are discussed below.  
In the following tables, constituents appear in blue type when the source is the concept definition 
6,7
, 
in green type when the source analysis is the qualitative exploration 
6
, and in red type when the source anal-
ysis is quantitative 
8
. 
Findings from the concept definition emerged from a search of the literature, compiling various us-
es of the concept and the qualitative exploration; findings from the qualitative analysis were generated 
inductively, and findings of the quantitative analysis evolved from a multivariable analysis, in which age, 
stable partnership, gender, symptom distress, highest completed educational degree, HADS total score, 
total functional support score, and number of perceived symptoms were integrated as potential correlates 
of perceived symptom manageability.  
Table 3.1. Antecedents – convergence coding matrix 
Concept Qualitative analysis Quantitative analysis 
 A symptom’s interference 
with social, professional,  
personal realms 
 (Symptom severity, frequency)  
 Symptom predictability 
 Symptom visibility  
 Symptom distress  
 Symptom severity 
 (Symptom frequency) 
  Illness uncertainty  Age 
 Depressive and anxiety  
symptomatology (HADS) 
  Availability and accessibility of  
symptom self-management strategies 
Silence 
  Availability and accessibility of  
information 
Silence 
  Accessible and available supportive 
network 
Silence (!) 
Agreement, partial agreement, silence, and dissonance in view of antecedents  
The above table makes it clear that there is almost no agreement between findings in view of ante-
cedents. There was partial agreement that interference related to symptom expression; the expression 
itself, however, was different between the qualitative and the quantitative findings. 
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Partial agreement also can be interpreted in terms of the existence of factors that influence percep-
tion, and that these are negative emotions. Availability and accessibility of various resources (own strate-
gies, information, social support) was found in the qualitative results, but not in the quantitative findings. 
This kind of convergence is called silence.  
Table 3.2. Defining attributes – convergence coding matrix 
Concept Qualitative analysis Quantitative analysis 
 Secure information, emotional 
and instrumental support as well 
as to apply tailored symptom 
management strategies 
  Targeting symptoms  Focus on perceived symptoms 
  Resource utilization:  
Self-management strategies  
Silence 
  Resource utilization: information,  
symptom control options 
Silence 
  Resource utilization: aid, affirmation, 
affect 
Silence(!) 
Agreement, partial agreement, silence, and dissonance in view of defining attributes 
Also in view of defining attributes, agreement between qualitative and quantitative results was 
scarce. Agreement was on the fact that the targets of manageability were symptoms. 
The use of resources was only mentioned in qualitative findings, and silence in quantitative findings. 
Table 3.3. Consequences – convergence coding matrix 
Concept Qualitative analysis Quantitative analysis 
 The perceived ability to keep  
interference at an acceptable  
level  
 Interference with every-day life 
in terms of 
o Lifestyle 
o disclosure  
o role performance  
 Individually perceived ability to 
keep interference tolerable 
Silence 
 
 
 
 
 Degree of manageability of  
perceived symptoms 
 
 
122 | CHAPTER 6 
 
Agreement, partial agreement, silence, and dissonance in view of consequences 
Agreement was found between concept definition and qualitative analysis, and partial agreement 
with quantitative findings. The convergence between quantitative and qualitative findings was silent in 
view of dimensions of interference with every-day life. 
In fact, it is to consider that the consecutive display rather serves the delineation of antecedents, at-
tributes, and consequences of the concept than represents a reality. As described in the model purported 
by Spirig et al. 
5
, all related elements are mutually influential. Symptom distress, which we position as a 
consequence, can be a substantial contributor to the development of depression 
9
 if manageability is not 
possible and a symptom affects every-day life. Perceived symptom manageability shapes disclosure, life-
style changes, life roles, and distress due to symptoms influencing further outcomes such as quality of life 
and adherence; and these consequences may also feed back into factors listed as antecedents.  
Completeness assessment 
As a structure to reflect the completeness of data, we employed the six-step approach by Moffatt et 
al. 
10
, which is recommended if there is silence or dissonance between findings to interrogate the datasets. 
First, the authors suggest comparing data sets in view of differences and further endorse to treat data sets 
as fundamentally different and therefore, results as complementary. As further steps, the authors suggest 
exploring the methodological rigor of each study and data set comparability, further data collection, inter-
vention evaluation (if applicable), and exploration if outcomes of integrated studies match.  
Comparison of data sets. In our case, the concept synthesis definition to be verified was, in parts, 
already modified using data from the qualitative analysis. The convergence between these two data sets 
relating to antecedents, defining attributes, and consequences, therefore, is not surprising. Quantitative 
and qualitative data sets, however, were generated by two fundamentally different analysis approaches, 
each answering a slightly different, yet complementary research question. It is, therefore, sensible to treat 
data as complementary and not as one cross-validating the other.  
The methodological rigor of each study seems adequate, within the limitations given by the sec-
ondary data analysis for both, the qualitative and the quantitative analysis.  
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Comparability of data sets. Comparability of data sets was limited. Again, limitations were mainly 
rooted in the secondary analysis, where data were given and could not be altered. Match of outcomes of 
quantitative and qualitative analyses. As analyses were planned parallel, constituents of the concept, 
which were explored within the qualitative analysis could only be integrated in the quantitative explora-
tion within narrow confines.  
Overall, due to the different methods employed and the slightly differing research questions as well 
as the limitations based on the secondary character of qualitative and quantitative data, the low degree of 
agreement between findings is not unexpected. However, the silence in view of social support is surpris-
ing, as social support was mentioned in almost every source used for the concept synthesis and identified 
as a major contributor to perceived symptom manageability in qualitative interviews. The collaboration of 
PLWH and support persons, to whom the HIV status was disclosed, was described as intimate and for 
many interviewees almost self-evident 
11
. This fact may have contributed to the answers provided to so-
cial support questions in the survey questionnaire, where social support is questioned in a distanced way 
and related to the entire social network, and the non-significance detected in the quantitative analysis.  
Overall, the concept encompasses situation-related as well as emotional and cognitive elements, as 
proposed, and seems comprehensive in view of its ability to detect symptoms that need management from 
diverse reasons, although this conclusion is preliminary and needs and further testing and verification.  
The construction of model cases and a borderline case based on constituents 
As the last step in concept synthesis, model cases for good and poor manageability and a borderline 
case were constructed. In order to construct model cases of poorly or well manageable symptoms, symp-
toms mentioned in the qualitative analysis were listed and coded using manageability appraisals from 
qualitative as well as rank orders from the quantitative analysis, as shown in the following table. 
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Table 4.: Convergence coding matrix and global assessment of symptom appraisals 
Symptom   Antecedents  Consequences 
 
Rank order 
Manageability  
(61 symptoms; 
N=268)1 
Combined 
appraisal2 
(convergence 
coding) 
Symptom expression: 
Among 10 most severe/ 
frequent/distressing:  
yes/no (ranks)3 
unpredictable/ 
visible/ 
treatable 
Interference with:  
Lifestyle (L) 
Disclosure (D) 
Role performance 
(Rp)5 
vomiting 1 1/- Yes (D)4(25/45/8) Yes/yes/(no) L, Rp 
hair loss 2 1/- No (44/n.a./38) No/yes/(no) (L) 
insomnia/can't sleep 3 1/- Yes (S,F,D) (2/3/2) Yes/no/yes L, Rp 
weight gain in stomach 
area 
4 1/- No (46/n.a./25) - /yes/(no) D 
skinny arms and legs 7 1/- No (24/n.a./32) - /yes/(no) D 
depressed mood 8 1/- No (40/38/13)  (yes)/(yes)/(yes) L, Rp 
fatigue 9 1/- Yes (S,F,D) (4/7/6) Yes/(yes)/(yes) L, (D), Rp 
caries/brittle teeth 10 1/- Yes (S, D) (10/n.a./3) -/yes/yes ? 
fear/worries 12 2/- Yes (F,D) (14/9/9) Yes/(no)/(yes) L, Rp 
memory loss 14 2/- No (60/37/20) (yes)/no/no L, Rp 
weakness 15 2/- No (27/11/15) Yes/yes/(no) L, Rp 
headaches 16 3/+ Yes (D) (19/40/1) Yes/no/yes L, Rp 
difficulty concentrating 17 3/- No (41/29/2)9 Yes/no/(no) L, Rp 
forgetfulness 26 3/- No (57/36/3)3 Yes/no/(no)  L, Rp 
weight loss 28 3/- No (39/n.a./47) - /yes/(yes) (D) 
diarrhea  38 3/+/- Yes (S, F) (7/10/21) (Yes)/(yes)/(yes) L, Rp 
weight gain 39 3/- No (53/n.a /56) - /yes/(yes) (D) 
dry skin 58 3/+ Yes (F) (17/1/50) No/no/yes - 
1  manageability ratings were between 3.5 (hair loss) and 4.6 (very poorly manageable = 1; poorly = 2; somewhat poorly = 3; somewhat 
well = 4; well = 5; very well = 6).  
2  Quantitative study: among the 10 (15) least manageable symptoms = 1 (2); later = 3; Qualitative study: poorly/well manageable (-/+)  
symptom groups: physical; body changes; mood and mind; energy and recreation   
3 rank symptom expression:  1=most severe/1=most frequent/1= most distressing 
4 (S, F, D): among ten most severe (S), frequently occurring (F), distressing (D) symptoms, as identified in the quantitative survey 
5 as appraised by interviewees 
Although many symptoms assessed in the quantitative exploration were not mentioned in qualita-
tive interviews, the majority of those explicitly mentioned were considered poorly manageable. Overall, 
there was an interesting concordance of qualitative and quantitative findings. More specifically, fifteen of 
18 symptoms mentioned in qualitative interviews were also rated as poorly manageable, and eleven of 
them ranged among the 15 least manageable symptoms as quantitatively explored. The 15 symptoms 
appraised as poorly manageable by interview participants were rated between "somewhat poorly" to 
"somewhat well" manageable across the entire sample and can be roughly assigned to 3 groups, namely 
body changes, such as weight gain in stomach area, or hair loss; symptoms referring to mood and mind 
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changes, such as forgetfulness or depressed mood, symptoms relating to energy and recreation, such as 
fatigue, weakness, or insomnia. Physical symptoms, such as diarrhea (if predictable) or dry skin, were 
considered as well manageable by interviewees and quantitatively rated as "somewhat well" to "well" 
manageable. The table also substantiates that relying on one of the traditionally used parameters may not 
be meaningful in terms of manageability of a symptom in daily living, and symptoms ranging among the 
15 least manageable symptoms did not necessarily range among least severe, frequent, or distressing 
symptoms. Dry skin, vomiting, and headaches are such examples: dry skin was rated as the most fre-
quently occurring symptom, but appraised as very well manageable quantitatively and in qualitative in-
terviews; vomiting was not among the ten least severe, frequently occurring or distressing symptom and 
was the least manageable symptom when not predictable; and headaches appeared as the most distressing 
symptom, but was rated as rather well manageable. Weight gain in stomach area, on the other side, was 
not ranging among the 10 most severe or distressing symptoms, but was rated as not well manageable due 
to its relation to HIV and its potential to unwantedly disclose someone's HIV status. 
In sum, it seems that traditionally used parameters were more meaningful if used in combination 
with additionally identified antecedents (predictability, visibility, treatability) or consequences as identi-
fied in the convergence coding matrices. What applied to almost all these symptoms was that they were 
appraised as intrusive on one or more of the domains of daily living by interviewees. Based on the above 
table, the construction of model cases of poor or good manageability and a borderline case in terms of 
symptoms was attempted:  
Construction of a model case of good symptom manageability: dry skin was mentioned as well 
manageable in qualitative interviews as well as rated in the same way in quantitative exploration.  
Mr. X, middle-aged, mentioned that this symptom was no problem, because he knew that it was 
due to ART (origin, predictability), and although occurring almost constantly and was rather severe, he 
perceived it as easy to treat by using a special soap and lotion (treatability). The symptom could not une-
quivocally be attributed to HIV and was not visible. There was no need for further information or support, 
Mr. X. has got a specific lotion from his health care provider. As Mr. X. has been living well with HIV, 
has built up trust in his medications and laboratory parameters. He said he was a positive-thinking person, 
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and there was no influencing factor impeding good manageability (age, uncertainty, depressive/anxiety 
symptomatology). The symptom caused no burden for Mr. X and did not interfere with any of his social, 
work (100%) or personal domains. 
Construction of a model case of poor manageability: Mr. Y, who is now in his late fifties, some-
times suffers from fatigue in the morning and thus has difficulty getting up and going to work in time. 
Colleagues, who are annoyed because he often turns up late at work, no longer invite him to join them for 
post-work social activities. What no one knew was that he had problems with resistant strains a few years 
ago and suggested changing ART because a friend had told him that the medications might be causing his 
problem and found corresponding information in an Internet blog. However, his provider was in a hurry 
and only hastily and negatively responded to Mr. Y’s request, by saying there is no certainty about the 
origin of his fatigue, and medication changes would not give any guarantee to reduce his symptom. Any-
way, he should rather agree to use antidepressants. Mr. Y was taking ART reluctantly, he thought they 
were poisonous and was not able to build up trust in chemicals. He observes anxiously any physical 
changes, expecting further signs of resistances and illness progression. As a consequence, Mr. Y only 
leaves his home to see the doctors or to work, does not talk to people and fears disclosure due to physical 
changes. Only his partner knows about his HIV status.  
Borderline case: diarrhea may be seen as borderline case – a symptom that does not fit the concept 
and was described as rather unmanageable despite its predictability, or due to its unpredictability. In both 
cases, after employing intrusive management strategies, the symptom became manageable: in the first 
case, integrating life changes (getting up 1.5 hours earlier in order to do proper toileting), and in the se-
cond case, using pads and mapping public toilets rendered the symptom more manageable. 
In sum, constructing model and borderline cases underscores the importance to complement the 
traditionally used parameters (symptom severity, frequency, or distress) by components relating to the 
daily living with symptoms and thus integrate a key concern of patients.  
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 REVIEW OF KEY FINDINGS 
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 REVIEW OF KEY FINDINGS 
With our mixed methods study, we explored "perceived symptom manageability," representing a 
new use of a known concept. By systematically combining findings from three analyses, we achieved a 
comprehensive representation of the concept. First, the theoretical definition extracted from current uses 
of the concept and the qualitative analysis enabled the conclusion to be made that the concept represents 
an individual view on a potentially difficult situation and components, which moderated the extent of 
difficulty. With the first integrative step, which combined the condensed uses of the concept with empiri-
cal data taken from interviews with patients, we succeeded in refining the theoretically developed work-
ing definition and transferring the concept to its intended new use. By integrating qualitative findings 
related to the concept, the modified definition of "perceived symptom manageability" represents the pa-
tients’ perspective on components of the concept. The second integration step facilitated the quantitative 
verification of the concept definition and its constituents, as well as embedding "perceived symptom 
manageability" in the wider context of a theoretical framework. This step resulted in a comprehensive 
representation of the concept and its constituents (global assessment, chapter 6, table 3), from which Key 
Finding 1 was derived. While our process ensured the integration of patient concerns into the new use of 
the concept, Key Finding 1 illustrates in what way concept components refer to PLWHs’ daily living with 
symptoms. In the last integrative step, the patients’ quantitative assessments and qualitative appraisals of 
symptoms mentioned in the qualitative interviews were combined (chapter 6, table 4) and allowed the 
exploration of the concepts’ potential to identify symptoms that need management, which is the subject of 
Key Finding 2.   
 
KEY FINDING 1  
 COMPONENTS OF THE CONCEPT ALLUDE TO NORMALIZING WITH SYMPTOMS 
The listing of findings as antecedents, attributes and consequences of perceived manageability of-
fers an interesting summary of its constituents, which clearly relate to normalization as part of chronic 
illness management. In fact, we can say that the concept represents a person’s perceived ability to use 
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resources within the struggle to achieve normalcy in view of potentially intrusive symptoms. We identi-
fied perceived manageability of a symptom as the ability to keep the interference of a symptom with eve-
ryday life tolerable. Moreover, most constituents of "perceived manageability" can be linked to normaliz-
ing, which is a core concern of persons living with chronic conditions 
12
. Normalizing refers to the efforts 
of persons living with a chronic illness to live their life "as normally as possible despite the symptoms and 
the disease" and is especially difficult if symptoms are fluctuating, regimens are changing; social interac-
tions and roles endangered, or the trajectory of the illness is perceived as fatal 
12
. For PLWH, who must 
live with many untreatable and potentially intrusive symptoms the success of normalization efforts can 
thus depend not on medical symptom control alone, but rather on the extent to which they succeed in 
keeping the intrusiveness of the illness and symptoms at a tolerable level. Perceived symptom managea-
bility, thus, refers to the perceived ability to lead a normal life despite potentially intrusive symptoms. To 
substantiate the link between concept constituents and normalizing, and thus our hypothesis that "per-
ceived symptom manageability" integrates PLWHs’ key concerns in terms of living with symptoms, we 
discuss antecedents, attributes, and consequences of the concept in the context of normalization.  
Antecedents of the concept are elements that affect perceived symptom manageability. Symptom 
control and expression, supportive network, and further influencing factors (as suggested in the frame-
work presented by Spirig et al. 
5
) were identified as such elements.  
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Cognitive parameters of symptom experience traditionally used to identify symptoms that need 
management, symptom severity and symptom frequency, were only implicitly mentioned by PLWH as 
relating to symptom manageability, but were substantially and negatively correlated with manageability 
in our quantitative analysis, pointing to the integration of these parameters in the concept.  
Symptom control and expression, especially visibility and predictability of symptoms seems especial-
ly forceful in view of symptom manageability referring to the fact that concealing symptoms is one way of 
keeping symptom intrusiveness on the social context controllable and ensure normalization in view of social 
relationships. Bodily changes, such as fat redistribution or extreme hair loss, were explicitly perceived as 
causing intolerable interference with everyday life in our qualitative analysis. Unpredictability in view of 
social consequences of a symptom may be related to fear of stigmatization 
13
 or social isolation. Since stig-
matization due to HIV is still a reality 
14
, visible symptoms may impede normalization by being related to 
unwanted disclosure and potentially negative reactions by the social context.  
Manageability of HIV symptoms seems, to a certain extent, to be related to the unpredictability that 
results from the individual, social, and illness-related consequences of these symptoms 
15
. Disruptions in 
daily living as a consequence of medication side effects did increase ambivalence and uncertainty in view 
of treatment 
16
. The sudden and unpredictable appearance of a symptom further demands day-to-day deci-
sions in view of medication adherence choices 
17
, self-care 
18
, or symptom and impairment management 
19
, 
thus impeding a normal daily routine. Living with "good and bad days" 
20
 relates, in parts, to the appear-
ance and expression of symptoms, which might also be unforeseeable, and requires a great flexibility and 
adaptability on the patient’s side and from the supportive network. A reliable and accessible supportive 
network providing aid, affirmation and affective support if needed is innately connected with normalization 
success, especially if symptoms are fluctuating, such as fatigue or sudden vomiting. The unpredictability of 
fluctuating symptoms requests permanent alertness and the ability to adapt from both, the person and the 
person’s supportive network. Moreover, in order to avoid non-productive interactions, PLWH withdrew 
from non-supportive relationships 
21
 which rather increased a feeling of uncertainty than providing a safe 
and understanding environment. Reinforcing productive social relationships, therefore, seems a compre-
hensible intervention to support PLWH, and responding to the PLWHs’ request to provide certainty, there-
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fore, represents an important task for health care providers in order to keep the patient/provider interaction 
fruitful and productive and enabling normalization support.  
Depressive and anxiety symptomatology is a well-known factor to negatively influence overall percep-
tion, 
22,23
. As both were identified as correlates of perceived symptom manageability in our quantitative analy-
sis, and frequently were mentioned in the interviews as relating to symptom manageability, we suggest both 
as antecedents, influencing the perception of symptom manageability. Recent findings support the notion that 
a negative mood state is unfavorably related to health-related quality of life, and that interventions should not 
only target physical but also the emotional well-being of PLWH 
24
. 
Because we suggest that traditionally used parameters to identify symptoms that need management do 
not sufficiently consider the emotional burden of living with symptoms, the finding that "illness uncertainty" 
substantially seemed to be an antecedent of perceived symptom manageability was interesting. While at-
tempting normalization, being reminded that medications can only retard decline may have deleterious effects 
on the interpretation of symptoms and their manageability in different patient populations 
25-28
. 
Also in PLWH, uncertainty continues to be part of the HIV trajectory and changes its form across the 
trajectory despite the life-saving effect of cART 
15,29
. Higher levels of uncertainty were related to increased 
mood disturbance and lower levels of overall quality of life 
30
 in a sample of PLWH, thus also potentially 
influencing the perception of symptom manageability. In the report of a qualitative investigation, partici-
pants described uncertainty as a fluctuating, episodic experience, relating to unforeseeable stages of feeling 
well or ill and disabled. Illness uncertainty, therefore, seems to affect normalization endeavors, and certain-
ty in terms of living with HIV and symptoms may be a condition to perceive normalization feasible. There 
is evidence that individual psychotherapy 
30
, cognitive behavioral therapy 
31
, or stress management training 
32
 was effective to reduce uncertainty in PLWH.  
Table 3.2 in chapter 6 shows integrated defining attributes. As we defined the use of the concept, it is 
comprehensible that symptoms were the target of manageability efforts. Core attributes of the theoretical 
definition and its refinement were relating to the ability of resource utilization: using self-management and 
management strategies, including control options, employing a supportive network 
11
 or accessing sources 
of information. Skilled use of resources was the core attribute of the concept and facilitated normalization. 
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For instance, to many patients, the use of complementary and alternative medicine was of substantial im-
portance to manage symptoms, emotions, and stigma 
33
; but many more resources were employed to live a 
normal life despite symptoms 
34
.  
Consequences pertain to elements affected by the concept. Interference with everyday life, especially in 
terms of lifestyle, disclosure, role performance, and symptom distress, which also correspond to self-
management dimensions identified by Nicca 
35,36
, were derived from the antecedents, and constitute the obsta-
cles to normalization if a symptom is not well manageable. Depending on the extent of symptom manageabil-
ity, these dimensions are influenced positively or negatively and impede or facilitate normalization.  
On the grounds of these reflections we summarize that traditionally used parameters, emotional 
elements, the individual contribution to living with symptoms, and self-management domains specifically 
important for PLWH in view of symptoms 
36
 need be included into efforts to support PLWHs’ strive for 
normalization within a chronic illness trajectory. Perceived symptom manageability, indeed, seems to 
capture a broad range of components meaningful to the situation of a PLWH and his or her ability to en-
gage in living a normal life with the illness. Traditionally used parameters to identify symptoms that need 
management do only capture a small, countable entity in this regard. Perceived symptom manageability, 
therefore, denotes the perceived ability to normalize in the midst of intrusive symptoms by engaging per-
sonal and social resources.  
KEY FINDING 2  
 THE CONCEPT HAS THE POTENTIAL TO IDENTIFY SYMPTOMS THAT  
 NEED MANAGEMENT 
In table 4 in chapter 6, symptoms with poor manageability were identified; first, by interviewees, and, 
secondly, by analyzing survey data. The majority of the symtpoms appraised as poorly manageable ranged 
among the 15 least manageable symptoms as assessed in the survey. Roughly, poorly manageable 
symptoms can be summarized as mood and mind-related symptoms, symptoms related to energy and 
recreation, and physical changes, which were identified concordantly as belonging to the least manageable 
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symptoms by two different approaches. Interestingly, although associated with negative health outcomes, 
many of the symptoms appraised as poorly manageable are often under-recognized and under-treated 
37,38
. 
We thus conclude that using the concept would enable the recognition of symptoms which need to 
be addressed due to their potential to impede normalization, and, therefore, considerably reduce 
emotional burden for patients. Emerging evidence that addressing the emotional situation of patients not 
only increases satisfaction with the health care encounter, but may facilitate adherence 
39
 and reduce 
perceived symptom burden 
40,41
 advocates the use of the concept in clinical encounters: The substantial 
negative correlation of perceived symptom manageability with symptom distress in our quantitative 
analysis highlights the emotional burden in case of symptoms impeding normalization due to their 
potential to interfere with a daily routine if treatment is not possible or difficult, as is often the case with 
symptoms related to mood and mind-related, energy and recreation, and physical changes. While mood- 
and mind-related symptoms and those referring to energy and recreation were interfering with leading a 
normal and productive life, physically visible symptoms were difficult to manage because of their 
unpredictable consequences in a wider social context. Despite the medically dominated public discourse, 
the emotional burden and management of the on-going adaptational and integrational work of those 
affected 
42
 and the importance of emotional support must not be underestimated. Kendall et al. 
43
 raise a 
critical voice addressing the current patient self-management discourse. They highlight that self-
management support by practitioners frequently overlooks the various ways in which persons with 
chronic illnesses manage their own body, experiences and health choices, by merely providing 
information and skills to (technically) manage the illness or symptom. Addressing and negotiating the 
tensions relating to the maintenance of a coherent identity, valued social roles and leading a normal life 
and ambiguous symptom management experiences in clinical encounters may establish context-specific 
opportunities to support patients and facilitate self-management 
44
.  
Employing a concept identifying mood and mind-related symptoms as well as those related to energy 
and recreation is important because these symptoms were not only burdensome for patients and their 
families but also found to be an important reason for non-adherence in PLWH: "forgetting pills" was the 
most common reason for not taking medications,  and daytime sleepiness and sleep problems may result in 
"sleeping through" dose time 
45
. Sleep problems may also contribute to more symptom burden and reduced 
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quality of life: of 290 adults, for instance, only 30% reported no sleep problems, and those reporting sleep 
problems, also reported significantly more anxiety symptoms and morning fatigue than good sleepers 
46
. 
Addressing the manageability of sleeping problems and worries, and initiate management strategies if 
manageability was poor, may, thus, contribute to better health outcomes in terms of symptom burden, 
quality of life and adherence. The individual strategies employed to enable a PLWH to live with fatigue, for 
instance use of illicit substances 
47,48
, underscore the importance of having an eye on these individually 
bothersome symptoms even though they are not immediately health-threatening.  
Changes affecting body image, especially facial atrophy, are recognized as HIV-related 
stigmatizing conditions and the impact on quality of life seems obvious. However, although measuring 
the patients’ perception of the impact of lipodystrophy on quality of life is difficult due to a lack of 
appropriate instruments  and no standardized definition of the bodily changes 
49
, receiving professional 
help, satisfaction with health care, and employing proactive coping strategies (all p<.05) were factors 
moderating the negative effect of stigma due to physical changes on adherence 
39
.   
The substantial correlation of our concept with symptom distress may raise the question of a 
conceptual overlap and needs to be further investigated. Clarifying if the invention of a new concept, 
indeed, is sensible, or if, for instance, bothersomeness or any measure integrating the emotional 
dimension of symptoms would also be a promising starting point to identify symptoms that need 
management is reasonnable. Recently published findings based on a reduced list of symptoms integrating 
symptom-specific questions on bothersomeness, for instance, show promising results. Using a tablet PC 
presenting a list of symptoms and a symptom algorithm prior to the health care visit substantially in-
creased the mutual understanding between health care provider and patient regarding symptoms 
50
. Em-
ploying a questionnaire which integrates the patients’ illness representation 51, satisfaction and tolerability 
52
, or a palliative care paradigm 
53, also show that including the patients’ perspective contributes to better 
outcomes. For instance, Harding and colleagues (2005) found that following a palliative care approach 
yields better patient outcomes with regard to the perception of pain and symptom control, anxiety symp-
tomatology, spiritual wellbeing, and understanding. The perception of being in control of HIV significant-
ly predicted a PLWH’s engagement in self-care activities: Engagement with provider, physical condition, 
and the illness representation domains of timeline, control, and identity were significantly associated with 
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self-care effectiveness 
51. Based on a recent study investigating physicians’ communication and its effect 
on adherence, the authors concluded that using Leventhal’s model as the foundation of communication 
resulted in better adherence ratings than the use of communication skills alone 
54
. The above endeavors, 
however, lack the inclusive and comprehensive perspective, which underlies our concept. 
Apart from the underlying perspective, practicability of such a measure is important. Assessing 
each patient using a list with all possible symptoms and symptom dimensions is, reasonably, not feasible. 
The use of an interactive, web-based tool to self-assess symptoms that need management, as suggested by 
Wantland, seems promising 
55
. This tool promotes, first, the targeted identification of individually bother-
ing symptoms before the planned visit. The symptoms identified then are used as the basis for the nego-
tiation of apt and individual management strategies. Although in this brief report on a pilot test several 
questions still needed clarification, such a tool, in which symptom manageability is rated, would poten-
tially facilitate the targeted discussion of symptom management strategies based on symptoms identified 
by patients. Identifying symptoms that need discussion by using a tablet PC before seeing a nurse or a 
doctor might, moreover, be one way of saving time and increase the productivity of the PLWH-health 
care provider encounter. 
In sum, despite other encouraging initiatives published lately, due to its comprehensibility in 
view of aspects potentially bothering for PLWH, perceived symptom manageability may represent 
a promising new approach to identify symptoms that need management.  
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FINAL REFLECTION AND REVIEW OF METHODS 
The study was designed and proposed as a descriptive exploratory cross-sectional investigation, 
using existing data. A mixed methods triangulation design 
2
 was used. Creating a triangulation protocol 
clarified the stages and procedures of integrating findings from methodologically different sources, and 
the overarching structure of concept synthesis proved to be useful to guide this process. The pragmatic 
approach allowed us to use the data as complementary rather than competing, and despite the fundamen-
tally different data, a comprehensive picture of the concept was achieved. 
In our original analysis plan, we proposed to test the mediatory effect of manageability, shaping 
the pathway between symptom experience and quality of life. Using path analytical techniques (struc-
tural equation modeling), the hypothesized mediating effect between symptom experience and outcome 
measure was not confirmed. This result was substantiated by conducting a parallel analysis employing 
the correlational procedure suggested by Baron & Kenny 
56
 for mediator testing. We, therefore, did not 
further pursue the mediatory hypothesis and concentrated on the concept exploration using concept syn-
thesis and the analysis of empirical data to verify the theoretical definition of the concept.  
The major limitation of the study was the use of existing data, collected for an overarching mixed 
method research project investigating symptom experience (SOLEXA). Although the overarching topic 
is very close to ours, the secondary use of empirical data did not permit, for instance, further questioning 
of PLWH when specific questions arose during the qualitative analysis, or participant checking. To part-
ly make up for this shortcoming, we invited two additional PLWH for the critical evaluation of a pre-
liminary visual representation of the main themes. Furthermore, our quantitative analysis was restricted 
to variables in the existing data set, therefore, interesting aspects, for instance, illness uncertainty or 
coping styles could not be integrated in the multivariate analysis. Therefore, although our findings seem 
comprehensive and contribute to the symptom management discourse, due to the secondary character or 
empirical data, our findings must be taxed as preliminary and need further verification and validation.  
A second shortcoming of the study is the limited generalizability of results due to the high attrition 
rate (Chapter 5) and the inclusion criteria, as our sample was predominantly Swiss and successfully treated 
with ART. Furthermore, for qualitative interviews, participants were purposefully chosen as dyads with a 
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close support person for the main analysis, which restricts the results of this analysis to PLWH in a close 
relationship. Moreover, although the most important validity evidence for an index was established, the 
publication of an article establishing evidence based on internal structure of the symptom list to investigate 
symptom prevalence, severity, frequency, distress and manageability is still pending 
57-59
. 
Although at the time when the study was planned, guidelines to develop patient reported 
outcomes (PRO) 
60
 have not yet been published, "perceived symptom manageability," in our opinion, 
represents a concept which has been identified by patients and integrates aspects important to them. 
There is an increasing understanding that user involvement is a prerequisite for successful chronic 
illness management 
61-63
 and the identification of symptoms that need management, as the first step for 
the successful negotiation of interventions and management strategies, therefore, needs to truly integrate 
the patients’ perspective. Perceived symptom manageability, therefore, can be seen as a sound basis to 
develop a patient reported outcome instrument as defined by the Food and Drug Administration 
(patient-reported outcomes, PRO) 
60,64
.  
IMPLICATIONS FOR FUTURE RESEARCH AND CLINICAL PRACTICE 
Future research 
Since our findings are based on secondary analyses of empirical data, we recommend further 
qualitative and quantitative studies providing primary data to substantiate the concept. Moreover, our 
interviewees were in a relatively stable condition and have been living with HIV and cART for years. 
Future research should be targeted at the applicability of our concept for PLWHs in more acute phases 
of the illness, for instance, immediately or shortly after testing positive or PLWH living in less resource-
affluent countries than Switzerland. 
Quantitative research: The strong negative correlation between symptom manageability and symp-
tom distress allows the hypothesis that these concepts represent opposite sides of a coin. As our design 
does not allow establishing causal relationships, longitudinal research needs to be conducted to clarify the 
relation. Testing a meditational effect of symptom manageability on the correlation of symptom expression 
parameters, such as symptom severity, predictability, visibility, and symptom distress would be another 
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option for further investigation. As the equilibrium between overall functional ability and symptom 
alleviation has also been identified as element of quality of life, future research should be targeted at 
relating perceived symptom manageability to quality of life. Our finding that certainty/uncertainty in view 
of living with HIV seems to play a key role in the perception of symptom manageability and some evi-
dence that uncertainty can be changed by targeted interventions could show a way to an intervention study 
aiming at increasing perceived symptom manageability by reducing illness uncertainty. 
Qualitative research: We identified the patients’ interpretation of "perceived symptom managea-
bility," but the PLWHs’ interpretation of "distress" is still unclear and needs clarification 65. Generating 
qualitative data on the patients’ definition of symptom distress, and then comparing the patients’ inter-
pretation of the concepts could be one way of doing so. Both pathways could refine our understanding 
of the concept and if "perceived symptom manageability" is going to expand, complement, or replace 
any of the currently used concepts.  
Instrument development: Developing a concise instrument for use in practice settings could be an 
aim for further research. Our integration findings provide excellent groundwork to develop an instru-
ment based on a concept and constituents important to patients. Further exploring concept attributes, 
antecedents, and consequences may serve as a starting point, informing more rigorous instrument devel-
opment and psychometric testing. Furthermore, using a tablet PC presenting a comprehensive list of 
symptoms and their manageability to be filled in beforehand could be an interesting starting point to 
think about longitudinal study designs, for instance, an intervention study targeting the increased 
productivity and satisfaction with the PLWH-health care provider encounter or adherence. 
Implications for clinical practice  
In clinical practice, symptoms that need management are frequently identified on the basis of 
cognitive aspects of symptom experience, i.e., symptom severity and/or frequency, and treatment 
necessity is concluded from these dimensions. Living with symptoms in every-day life, however, is often 
acompagnied by emotional and practical burden relating to normalization which is not yet routinely 
integrated in the identification of symptoms that need management. The integration of findings from our 
analyses revealed defining attributes, antecedents and consequences of "perceived symptom 
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manageability," which all present areas for intervention for health care providers. Basically, we found that 
"perceived symptom manageability" is a useful concept for identifying symptoms that need management 
because it provides a wider perspective on a life with symptoms than traditionally used parameters.  
For instance, understanding and acknowledging a PLWHs’ need for affirmation by 
acknowledging the emotional burden especially if medical control of the symptom is not possible, but 
also the uncertainty and worries that may go with any symptom despite treatment options, may increase 
satisfaction of the encounter on both sides. Addressing potential concerns relating to a variety of topics 
relating to daily living with fluctuating and partly debilitating symptoms, facilitating self-efficacy, 
supporting self-management tasks and skills, providing affirmation and acknowledging emotional 
burden as legitimate reason to treat/negotiate a symptom are further recommendations to enhance 
normalization. 
CONCLUSION 
Symptom experience assessment and the identification of symptoms that need management cur-
rently mainly rely on parameters describing symptom expression. Important elements of the lived expe-
rience of living with a chronic illness, and associated emotional burden, however, are frequently ne-
glected. Our findings bring forth first evidence that perceived symptom manageability is a concept that 
holds promise to enable mutual understanding between health care providers and patients by embracing 
not only cognitive but also emotional aspects of living with symptoms and integrates the challenges 
pertaining to the daily living with a chronic condition. Most importantly, by assessing "perceived symp-
tom manageability" to identify symptoms that need management, health care providers acknowledge the 
existence of illness uncertainty and emotional burden despite good medical treatment and prevailing 
logic reasoning as rationale for symptom management interventions.  
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